Document:

<PAGE>

                                                                    Exhibit 10.4

NEITHER THIS WARRANT NOR ANY OF THE SECURITIES INTO WHICH THIS WARRANT MAY BE
EXERCISED HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
"SECURITIES ACT") OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD,
PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE
SECURITIES LAWS, OR ANY OPINION OF COUNSEL REASONABLY ACCEPTABLE TO THE COMPANY
AND ITS COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED. THE SECURITIES HAVE NOT
BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION OR ANY
STATE SECURITIES COMMISSION.

Warrant No. 2003-21                                    Number Of Shares: 66,786
Date of Issuance:  June 27, 2003

                           WARRANT TO PURCHASE SHARES
                               OF COMMON STOCK OF

                                 ORTHOVITA, INC.

     This Warrant is issued to SG Cowen Securities Corporation, or its
registered assigns ("Investor"), pursuant to that certain Securities Purchase
Agreement dated as of June 26, 2003 between Orthovita, Inc., a Pennsylvania
corporation ("Orthovita"), and Investor (the "Purchase Agreement") and is
subject to the terms and conditions of the Purchase Agreement.

1.   Exercise of Warrant. Subject to the terms and conditions herein set forth,
upon surrender of this Warrant at the principal office of Orthovita and upon
payment of the Warrant Price (as defined below) by wire transfer to Orthovita or
cashiers check drawn on a United States bank made to the order of Orthovita,
Investor is entitled to purchase from Orthovita, at any time after the date
hereof and on or before June 26, 2008 (the "Expiration Date"), up to 66,786
shares (as adjusted from time to time pursuant to the provisions of this
Warrant) of common stock, par value $0.01 per share (the "Common Stock"), of
Orthovita (the "Warrant Shares"), at a purchase price of $4.00 per share (the
"Warrant Price").

2.   Certain Adjustments. So long as this Warrant is outstanding:

     (a) Mergers or Consolidations. If at any time after the date hereof there
shall be a capital reorganization (other than a combination or subdivision of
Warrant Shares otherwise provided for herein) (a "Reorganization"), or a merger
or consolidation of Orthovita with another corporation (other than a merger with
another corporation in which Orthovita is a continuing corporation and which
does not result in any reclassification or change of outstanding securities
issuable upon exercise of this Warrant or a merger effected exclusively for the
purpose of changing the domicile of Orthovita ) (a "Merger"), then, as a part of
such Reorganization or Merger, lawful provision shall be made so that Investor
shall thereafter be entitled to receive upon exercise of this Warrant, during
the period specified in this Warrant and upon payment of the Warrant Price, the
number of shares of stock or other securities or property of Orthovita or the
successor corporation resulting from such Reorganization or Merger, to which a
holder of the Common Stock deliverable upon exercise of this Warrant would have
been entitled under the provisions of the agreement in such Reorganization or
Merger if this Warrant had been exercised immediately before that Reorganization
or Merger. In any such case, appropriate adjustment (as determined in good faith
by Orthovita's Board of Directors) shall be made in the application of the
provisions of this Warrant with respect to the rights and interests of Investor
after the Reorganization or Merger to the end that the provisions of this
Warrant (including adjustment of the Warrant Price then in effect and the number
of shares of Warrant Shares) shall be applicable after that event, as near as
reasonably may be, in relation to any shares or other property deliverable after
that event upon exercise of this Warrant.

<PAGE>

     (b) Splits and Subdivisions; Dividends. In the event Orthovita should at
any time or from time to time fix a record date for the effectuation of a split
or subdivision of the outstanding shares of Common Stock or the determination of
the holders of Common Stock entitled to receive a dividend or other distribution
payable in additional shares of Common Stock or other securities or rights
convertible into, or entitling the holder thereof to receive directly or
indirectly, additional shares of Common Stock (hereinafter referred to as the
"Common Stock Equivalents") without payment of any consideration by such holder
for the additional shares of Common Stock or Common Stock Equivalents (including
the additional shares of Common Stock issuable upon conversion or exercise
thereof), then, as of such record date (or the date of such distribution, split
or subdivision if no record date is fixed), the per share Warrant Price shall be
appropriately decreased and the number of shares of Warrant Shares shall be
appropriately increased in proportion to such increase (or potential increase)
of outstanding shares.

     (c) Combination of Shares. If the number of shares of Common Stock
outstanding at any time after the date hereof is decreased by a combination of
the outstanding shares of Common Stock, the per share Warrant Price shall be
appropriately increased and the number of shares of Warrant Shares shall be
appropriately decreased in proportion to such decrease in outstanding shares.

     (d) Adjustments for Other Distributions. In the event Orthovita shall
declare a distribution payable in securities of other persons, evidences of
indebtedness issued by Orthovita or other persons, assets (excluding cash
dividends paid out of net profits) or options or rights not referred to in
Section 2(b), then, in each such case for the purpose of this Section 2(d), upon
exercise of this Warrant the holder hereof shall be entitled to a proportionate
share of any such distribution as though such holder was the holder of the
number of shares of Common Stock of Orthovita into which this Warrant may be
exercised as of the record date fixed for the determination of the holders of
Common Stock of Orthovita entitled to receive such distribution.

     (e) Adjustments for Dilutive Issuances. Except as otherwise provided in
Section 2(f) and Section 2(g) hereof, if prior to the Expiration Date, the
Company issues or sells, or in accordance with Section 2(f) is deemed to have
issued or sold, any shares of Common Stock for no consideration (other than a
stock split or stock dividend) or for a consideration per share less than the
Warrant Price (as then in effect) (a "Dilutive Issuance"), then effective
immediately upon such Dilutive Issuance (which shall include the actual number
of shares outstanding plus all shares issuable upon the conversion or exercise
of all outstanding convertible securities, warrants and options), the adjusted
Warrant Price will be equal to the quotient obtained by dividing (A) the then
current Warrant Price multiplied by the sum of (i) the number of shares of
Common Stock outstanding immediately prior to the Dilutive Issuance plus (ii)
the quotient of the aggregate consideration, calculated as set forth in Section
2(f), received by the Company upon such Dilutive Issuance divided by the then
current Warrant Price; by (B) the total number of shares of Common Stock deemed
outstanding immediately after the Dilutive Issuance which shall include the
actual number of shares outstanding plus all shares issuable upon the conversion
or exercise of all outstanding convertible securities, warrants and options.

     (f) Effect on Exercise Price of Certain Events. For purposes of determining
the adjusted Exercise Price under Section 2(e), the following will apply:

         (i) Issuance of Rights, Options or Convertible Securities. Subject to
Section 2(f)(ii) below, if, after the date hereof, the Company issues or grants
any warrants, rights or options, whether or not immediately exercisable, to
subscribe for or to purchase Common Stock or other securities exercisable,
convertible into or exchangeable for Common Stock ("Convertible Securities")
(such warrants, rights and options to purchase Common Stock or Convertible
Securities are hereinafter referred to as "Options"), and the price per share
for which Common Stock is purchasable or issuable upon the exercise of such
Options is less than the Warrant Price (as then in effect) on the date of
issuance of such Option or direct stock grant (collectively, "Below Market
Options"), then the maximum total number of shares of Common Stock issuable upon
the exercise of all such Below Market Options (assuming full exercise,
conversion or exchange of Convertible Securities, if applicable) will, as of the
date of the issuance or grant of such Below Market Options, be deemed to be
outstanding and to have been issued and sold by the Company for such

                                       2

<PAGE>

price per share. For purposes of the preceding sentence, the price per share for
which Common Stock is issuable upon the exercise of such Below Market Options is
determined by dividing (i) the total amount, if any, received or receivable by
the Company as consideration for the issuance or sale of all such Below Market
Options, plus the minimum aggregate amount of additional consideration, if any,
payable to the Company upon the exercise of all such Below Market Options, plus,
in the case of Convertible Securities issuable upon the exercise of such Below
Market Options, the minimum aggregate amount of additional consideration payable
upon the exercise, conversion or exchange thereof at the time such Convertible
Securities first become exercisable, convertible or exchangeable, by (ii) the
maximum total number of shares of Common Stock issuable upon the exercise of all
such Below Market Options (assuming full conversion of Convertible Securities,
if applicable). No further adjustment to the Warrant Price will be made upon the
exercise of such Below Market Options or upon the exercise, conversion or
exchange of Convertible Securities issuable upon exercise of such Below Market
Options.

          (ii)  Issuance of Convertible Securities.

                If the Company issues or sells any Convertible Securities,
whether or not immediately convertible (other than where the same are issuable
upon the exercise of Options) and the price per share for which Common Stock is
issuable upon such exercise, conversion or exchange (as determined pursuant to
Section 2(f)(i) if applicable) is less than the Warrant Price (as then in
effect) on the date of issuance of such Convertible Security, then the maximum
total number of shares of Common Stock issuable upon the exercise, conversion or
exchange of all such Convertible Securities will, as of the date of the issuance
of such Convertible Securities, be deemed to be outstanding and to have been
issued and sold by the Company for such price per share. For the purposes of the
preceding sentence, the price per share for which Common Stock is issuable upon
such exercise, conversion or exchange is determined by dividing (i) the total
amount, if any, received or receivable by the Company as consideration for the
issuance or sale of all such Convertible Securities, plus the minimum aggregate
amount of additional consideration, if any, payable to the Company upon the
exercise, conversion or exchange thereof at the time such Convertible Securities
first become exercisable, convertible or exchangeable, by (ii) the maximum total
number of shares of Common Stock issuable upon the exercise, conversion or
exchange of all such Convertible Securities. No further adjustment to the
Warrant Price will be made upon the actual issuances of such Common Stock upon
exercise, conversion or exchange of such Convertible Securities.

          (iii) Change in Option Price or Conversion Rate. If there is a change
at any time in (i) the amount of additional consideration payable to the Company
upon the exercise of any Options; (ii) the amount of additional consideration,
if any, payable to the Company upon the exercise, conversion or exchange of any
Convertible Securities, or (iii) the rate at which any Convertible Securities
are convertible into or exchangeable for Common Stock (other than under or by
reason of provisions designed to protect against dilution), the Warrant Price in
effect at such time shall be adjusted to the Warrant Price which would have been
in effect had such Options or Convertible Securities still outstanding provided
for such changed additional consideration or changed conversion rate, as the
case may be, at the time initially granted, issued or sold.

          (iv)  Treatment of Expired Options and Unexercised Convertible
Securities. If, in any case, the total number of shares of Common Stock issuable
upon exercise of any Options or upon exercise, conversion or exchange of any
Convertible Securities is not, in fact, issued and the rights to exercise such
Option or to exercise, convert or exchange such Convertible Securities shall
have expired or terminated, the Warrant Price then in effect will be readjusted
to the Warrant Price which would have been in effect at the time of such
expiration or termination had such Options or Convertible Securities, to the
extent outstanding immediately prior to such expiration or termination (other
than in respect of the actual number of shares of Common Stock issued upon
exercise or conversion thereof), never been issued.

          (v)   Calculation of Consideration Received. If any Common
Stock, Options or Convertible Securities are issued, granted or sold for cash,
the consideration received therefor for purposes of this Warrant will be the
amount received by the Company therefor, before deduction of reasonable

                                       3

<PAGE>

commissions, underwriting discounts or allowances or other reasonable expenses
paid or incurred by the Company in connection with such issuance, grant or sale.
In case any Common Stock, Options or Convertible Securities are issued or sold
for a consideration part or all of which shall be other than cash, the amount of
the consideration other than cash received by the Company will be the fair
market value of such consideration except where such consideration consists of
freely-tradable securities, in which case the amount of consideration received
by the Company will be the market price thereof as of the date of receipt. The
fair market value of any consideration other than cash or securities will be
determined in the good faith reasonable business judgment of the Board of
Directors.

     (g) Exceptions to Adjustment of Exercise Price. No adjustment to the
Warrant Price or the number of Warrant Shares issuable pursuant to this Warrant
will be made under Section 2(e) or 2(f) above as a result of the issuance of any
securities of the Company issued pursuant to (i) the grant or exercise of any
stock or options which may hereafter be granted or exercised under any employee,
consultant or director benefit plan of the Company now existing or implemented
in the future, so long as the issuance of such stock or options is approved by a
majority of the non-employee members of the Company's Board of Directors or a
majority of the members of a committee of non-employee directors established for
such purpose, (ii) any options, warrant, preferred stock, convertible securities
or rights or agreements to purchase securities of the Company (not including
equity lines of credit) outstanding on the date hereof; (iii) any underwritten
public offerings of equity securities (other than equity lines of credit and
similar transactions); (iv) any equity securities issued for consideration other
than cash pursuant to a merger, consolidation, acquisition or similar business
combination; (v) shares of Common Stock issued in connection with any stock
split, stock dividend or recapitalization by the Company; (vi) shares of Common
Stock issued upon exercise of the Warrants or any warrants issued in connection
with the Securities Purchase Agreements (as defined below); (vii) any equity
securities issued pursuant to any equipment leasing arrangement or debt
financing from a bank or similar financial institution whose primary business is
lending money and not investing in securities; or (viii) any equity securities
(other than equity lines of credit) issued in connection with strategic
transactions involving the Company and other entities, including (A) joint
ventures, manufacturing, marketing or distribution arrangements, (B) technology
transfer or development arrangements; provided, that the primary purpose of such
transaction is not the raising of capital; (ix) an agreement to issue securities
which does not close; (x) any securities issued or issuable under the Securities
Purchase Agreements entered into by and between the Company and certain
investors (including the original holder of this Warrant) on the date of
original issuance of this Warrant (collectively, the "Securities Purchase
Agreements"), pursuant to which such investors agreed to purchase shares of
common stock and common stock purchase warrants from the Company, (xi) any
common stock purchase warrants issued or issuable to the placement agent
described in the Securities Purchase Agreements, or any shares of common stock
issuable thereunder; and (xii) any shares of common stock issued as payment in
kind on the shares of the Company's Series A Convertible Preferred Stock
outstanding on the date hereof.

3.   No Fractional Shares. No fractional shares of Warrant Shares will be issued
in connection with any exercise of this Warrant. In lieu of any fractional
shares which would otherwise be issuable, Orthovita shall pay cash equal to the
product of such fraction multiplied by the Fair Market Value of one share of
Warrant Shares. The "Fair Market Value" of a share of Common Stock shall mean
the last reported sale price and, if there are no sales, the last reported bid
price, of the Common Stock on the business day prior to the Date of Exercise (as
defined below) as reported by the Nasdaq National Market or such other principal
exchange or quotation system on which the Common Stock is then traded or, if the
Common Stock is not publicly traded, the price determined in good faith by
Orthovita's Board of Directors.

4.   No Shareholder Rights. This Warrant does not entitle Investor to any voting
or other rights as a shareholder of Orthovita (including without limitation the
right to notification of shareholder meetings or the right to receive any notice
or other communication concerning the business and affairs of Orthovita ) prior
to the exercise and payment of the Warrant Price in accordance with the terms of
Sections 1 and 6 hereof.

                                       4

<PAGE>

5.   Reservation of Stock. Orthovita covenants that during the period this
Warrant is exercisable, Orthovita will reserve from its authorized and unissued
shares of Common Stock a sufficient number of shares of Common Stock (or other
securities, if applicable) to provide for the issuance of Warrant Shares (or
other securities) upon the exercise of this Warrant. Orthovita agrees that its
issuance of this Warrant shall constitute full authority to its officers who are
charged with the duty of executing stock certificates to execute and issue the
necessary certificates for the Warrant Shares upon the exercise of this Warrant.
All such Warrant Shares shall, upon issuance and payment of the exercise price,
be duly and validly authorized, fully-paid and non-assessable.

6.   Mechanics of Exercise. This Warrant may be exercised by the holder hereof,
in whole or in part, by the surrender of this Warrant and the Notice of Exercise
attached hereto as Exhibit A duly completed and executed on behalf of the holder
hereof, at the principal office of Orthovita together with payment in full of
the Warrant Price then in effect with respect to the number of shares of Warrant
Shares as to which the Warrant is being exercised. The date on which the Company
receives this Warrant, duly completed and executed Notice of Exercise and
payment in full of the Warrant Price is referred to herein as the "Date of
Exercise"; provided that if the Company receives such items on a day that is not
a business day or after 5:30 p.m. Eastern Time on a business day, then the Date
of Exercise shall be the next business day, This Warrant shall be deemed to have
been exercised immediately prior to the close of business on the Date of
Exercise as provided above, and the person entitled to receive the Warrant
Shares issuable upon such exercise shall be treated for all purposes as the
holder of such shares of record as of the close of business on such date. As
promptly as practicable on or after such date, Orthovita at its expense shall
cause to be issued and delivered to the person or persons entitled to receive
the same a certificate or certificates for the number of full shares of Warrant
Shares issuable upon such exercise, together with cash in lieu of any fraction
of a share as provided above. The shares of Warrant Shares issuable upon
exercise hereof shall, upon their issuance, be validly issued, fully paid and
nonassessable, and free from all preemptive rights, taxes, liens and charges
with respect to the issue thereof. In the event that this Warrant is exercised
in part, Orthovita at its expense will execute and deliver a new Warrant of like
tenor exercisable for the number of shares for which this Warrant may then be
exercised.

If by the third business day after the Date of Exercise the Company fails to
deliver the required number of Warrant Shares in the manner required pursuant to
this Section 6, then the Investor will have the right to rescind such exercise.
If by the third business day after the Date of Exercise the Company fails to
deliver the required number of Warrant Shares in the manner required pursuant to
this Section 6, and if after such third business day and prior to the receipt of
such Warrant Shares, the Investor purchases (in an open market transaction or
otherwise) shares of Common Stock to deliver in satisfaction of a sale by the
Investor of the Warrant Shares which the Investor anticipated receiving upon
such exercise (a "Buy In"), then the Company shall either (1) pay in cash to the
Investor the amount by which (x) the Investor's total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased
exceeds (y) the amount obtained by multiplying (A) the number of Warrant Shares
that the Company was required to deliver to the Investor in connection with the
exercise at issue by (B) the closing bid price of the Common Stock on the date
on which the Investor delivered the Notice of Exercise or (2) at the option of
the Investor, either reinstate the portion of the Warrant and equivalent number
of Warrant Shares for which such exercise was not honored or deliver to the
Investor the number of shares of Common Stock that would have been issued had
the Company timely complied with its exercise and delivery obligations
hereunder. The Investor shall provide the Company written notice indicating the
amounts payable to the Investor in respect of the Buy In. The Company's
obligations to issue and deliver Warrant Shares in accordance with the terms
hereof are absolute and unconditional, irrespective of any action or inaction by
the Investor to enforce the same, any waiver or consent with respect to any
provision hereof, the recovery of any judgment against any person or any action
to enforce the same, or any setoff, counterclaim, recoupment, limitation or
termination, or any breach or alleged breach by the Investor or any other person
of any obligation to the Company or any violation or alleged violation of law by
the Investor or any other person, and irrespective of any other circumstance
which might otherwise limit such obligation of the Company to the Investor in
connection with the issuance of Warrant Shares. Nothing herein shall limit a
Investor's right to pursue any other remedies available to it hereunder, at law
or in equity including, without limitation, a decree of specific performance
and/or injunctive relief with respect to the Company's failure to timely deliver

                                       5

<PAGE>

certificates representing shares of Common Stock upon exercise of the Warrant as
required pursuant to the terms hereof.

7.   Certificate of Adjustment. Whenever the Warrant Price or number or type of
securities issuable upon exercise of this Warrant is adjusted, as herein
provided, Orthovita shall, at its expense, promptly deliver to the record holder
of this Warrant a certificate of an officer of Orthovita setting forth the
nature of such adjustment and showing in detail the facts upon which such
adjustment is based.

8.   Representations of Investor. As of the date hereof, Investor hereby
confirms the representations and warranties made by Investor in Section 5 of the
Purchase Agreement.

9.   Transfer Restrictions. The holder of this Warrant acknowledges that this
Warrant and the Warrant Shares have not been registered under the Securities
Act, and agrees not to offer, sell, pledge, transfer or otherwise dispose of (or
solicit any offers to buy, purchase or otherwise acquire or take a pledge of)
this Warrant or any Warrant Shares issued upon its exercise except in compliance
with the Securities Act, applicable state securities laws and the respective
rules and regulations promulgated thereunder. If, at the time of the surrender
of this Warrant in connection with any transfer of this Warrant or the Warrant
Shares, this Warrant or the Warrant Shares, as applicable, shall not be
registered under the Securities Act and under applicable state securities or
blue sky laws, Orthovita may require, as a condition of allowing such transfer
that the holder or transferee of this Warrant or the Warrant Shares as the case
may be, furnish to Orthovita the Notice of Assignment Form attached hereto as
Exhibit B and a written opinion of counsel that is reasonably acceptable to
Orthovita to the effect that such transfer may be made without registration
under the Securities Act and under applicable state securities or blue sky laws,
(ii) that the holder or transferee execute and deliver to Orthovita an
investment letter in form and substance acceptable to Orthovita and (iii) that
the transferee be an "accredited investor" as defined in Rule 501(a) promulgated
under the Securities Act. Each certificate or other instrument for Warrant
Shares issued upon the exercise of this Warrant shall bear a legend
substantially to the foregoing effect. The holder of this Warrant must obtain
the prior written consent of Orthovita in order to transfer Warrants
representing the right to purchase fewer than the lesser of (x) 50,000 Warrant
Shares or (y) the number of Warrant Shares for which this Warrant is then
exercisable.

10.  Redemption. The Company may, at its option, redeem this Warrant, in whole
or in part, at any time, provided that (i) the volume weighted average closing
price of the Common Stock as reported by Bloomberg, L.P. or any successor
thereof on twenty (20) of any thirty (30) consecutive trading days has been at
least 200% above the Warrant Price and (ii) during the time period described in
clause (i) of this Section 10 and for the Notice Period (as defined below), all
of the Warrant Shares underlying the Warrants to be redeemed are then registered
under an effective registration statement in accordance with the terms and
conditions of Section 7.1 of the Securities Purchase Agreement which has not
been suspended and for which no stop order is in effect, and pursuant to which
the Investor is able to sell such Warrant Shares . The amount payable in
redemption of the rights to purchase the Warrant Shares pursuant to this Section
10 shall be cash equal to $0.01 multiplied by the number of Warrants being
redeemed. The Company must give the Investor at least thirty (30) days' prior
notice (the "Notice Period") (which notice shall include the redemption price,
the redemption date and a statement that until such date, the Warrants may be
exercised in accordance with the terms of this Warrant) in order to exercise its
right of redemption under this Section 10, and the Investor may not exercise
this Warrant after the Notice Period has expired.

11.  Notices of Record Date. In the event of:

     (a) any taking by Orthovita of a record of the holders of any class of
securities for the purpose of determining the holders thereof who are entitled
to receive any dividend (other than a cash dividend payable out of earned
surplus of Orthovita) or other distribution, or any right to subscribe for,
purchase or otherwise acquire any shares of stock of any class or any other
securities or property, or to receive any other right; or

     (b) any Reorganization or Merger; or

                                       6

<PAGE>

     (c) any voluntary or involuntary dissolution, liquidation or winding-up of
Orthovita,

then and in each such event Orthovita will mail or cause to be mailed to the
holder of this Warrant a notice specifying (i) the date on which any such record
is to be taken for the purpose of such dividend, distribution or right, and
stating the amount and character of such dividend, distribution or right, and
(ii) the date on which any such Reorganization, Merger, dissolution, liquidation
or winding-up is to take place, and the time, if any, as of which the holders of
record of Common Stock (or other securities) shall be entitled to exchange their
shares of Common Stock (or other securities) for securities or other property
deliverable upon such Reorganization, Merger, dissolution, liquidation or
winding-up. Such notice shall be mailed at least ten (10) business days prior to
the date therein specified.

12.  Replacement of Warrants. On receipt of evidence reasonably satisfactory to
Orthovita of the loss, theft, destruction or mutilation of this Warrant and, in
the case of any such loss, theft or destruction of this Warrant, on delivery of
an indemnity agreement or security reasonably satisfactory in form and amount to
Orthovita or, in the case of any such mutilation, on surrender and cancellation
of such Warrant, Orthovita at its expense will execute and deliver, in lieu
thereof, a new Warrant of like tenor.

13.  No Impairment. Except to the extent as may be waived by the holder of this
Warrant, Orthovita will not, by amendment of its charter or through a
Reorganization, Merger, dissolution, sale of assets or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms
of this Warrant, but will at all times in good faith assist in the carrying out
of all such terms and in the taking of all such action as may be necessary or
appropriate in order to protect the rights of the holder of this Warrant against
impairment.

14.  Saturdays, Sundays, Holidays, Etc. If the last or appointed day for the
taking of any action or the expiration of any right required or granted herein
shall be a Saturday or Sunday or shall be a legal holiday, then such action may
be taken or such right may be exercised on the next succeeding day not a
Saturday, Sunday or legal holiday.

15.  Miscellaneous. This Warrant shall be governed by the laws of the State of
New York without regard to principles of conflicts of law. The headings in this
Warrant are for purposes of convenience and reference only, and shall not be
deemed to constitute a part hereof. Neither this Warrant nor any term hereof may
be changed, waived, discharged or terminated orally but only by an instrument in
writing signed by Orthovita and the Investor. All notices and other
communications from Orthovita to the holder of this Warrant shall be sufficient
if in writing and sent by registered or certified mail, domestic or
international courier, or facsimile, return receipt requested, postage or
courier charges prepaid, to the address furnished to Orthovita in writing by
Investor. All such notices and communications shall be effective (i) upon
delivery, if delivered personally, (ii) upon verification of transmittal by
sender, if by facsimile, (iii) five days after deposit in the mail, if by
registered or certified mail (return receipt requested), postage prepaid, or
(iv) on the next business day, if sent by express courier service, and if to
Orthovita, with a copy to Richard A. Silfen, Esquire of Morgan, Lewis & Bockius
LLP, 1701 Market Street, Philadelphia, PA 19103 (facsimile 215.963.5001). The
invalidity or unenforceability of any provision hereof shall in no way affect
the validity or enforceability of any other provisions.

                                       7

<PAGE>

         IN WITNESS WHEREOF, this Warrant to Purchase Common Stock is issued
effective as of this 27th day of June 2003.

                                     ORTHOVITA, INC.

                                     By: ANTONY KOBLISH
                                         ----------------------
                                         Antony Koblish, Chief Executive Officer

                          SIGNATURE PAGE TO THE WARRANT
                       TO PURCHASE SHARES OF COMMON STOCK

                                       8

<PAGE>

                       EXHIBIT A - to the Form of Warrant

                          NOTICE OF INTENT TO EXERCISE
                  (To be signed only upon exercise of Warrant)

To:  ORTHOVITA, INC.

     The undersigned, the holder of the attached Warrant, hereby confirms the
representations and warranties set forth in Section 5 of that certain Securities
Purchase Agreement dated as of June __, 2003 and irrevocably elects to exercise
the purchase right represented by such Warrant for, and to purchase thereunder,
______________ (________) shares of Common Stock of Orthovita, Inc. and herewith
makes payment of _________________ Dollars ($_________) therefor and requests
that the certificates for such shares be issued in the name of, and delivered to
___________________________, whose address is__________________________________.

DATED:________________________________________

                                    (Signature must conform in all respects to
                                    name of Investor as specified on the face of
                                    the Warrant)

                                    ____________________________________________
                                    ____________________________________________
                                    (Address) __________________________________
                                    ____________________________________________

                                       i

<PAGE>

                       EXHIBIT B - to the Form of Warrant

                            NOTICE OF ASSIGNMENT FORM

     FOR VALUE RECEIVED, ______________________ (the "Assignor") hereby sells,
assigns and transfers all of the rights of the undersigned Assignor under the
attached Warrant with respect to the number of shares of common stock of
Orthovita, Inc. (the "Company") covered thereby set forth below, to the
following "Assignee" and, in connection with such transfer, represents and
warrants to the Company that the transfer is otherwise in compliance with
Section 9 of the Warrant:

Name of Assignee             Address/Fax Number              No. of Shares
----------------             ------------------              -------------

___________________       _______________________      ________________________

___________________       _______________________      ________________________

Dated:_____________________                 Signature:

                                            _________________________________

                                            Witness:

                                            _________________________________

                            ASSIGNEE ACKNOWLEDGEMENT

     The undersigned Assignee acknowledges that it has reviewed the attached
Warrant and by its signature below it hereby represents and warrants that it is
an "accredited investor" as defined in Rule 501(a) of Regulation D promulgated
under the Securities Act of 1933, as amended, and agrees to be bound by the
terms and conditions of the attached Warrant as of the date hereof.

                                          Signature:

                                          By:______________________________

                                          Its:_____________________________

                                          Address: ________________________
                                          _________________________________

                                       iiIndenture, dated as of June 6, 2003

  
 Exhibit 4.1

  
 GREENPOINT FINANCIAL CORP., 
 as Issuer 
  
 3.20% SENIOR NOTES DUE 2008 
  
 INDENTURE 
  
 Dated as of
June 6, 2003 
  
 The BANK OF NEW YORK, 
 as Trustee 

 Table of Contents 
  

	 	  	 	  	Page

	
	ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE
			
	Section 1.1	  	Definitions	  	1
	Section 1.2	  	Incorporation by Reference of Trust Indenture Act	  	5
	 Section 1.3
	  	Rules of Construction	  	6
	
	ARTICLE II THE NOTES
			
	Section 2.1	  	Form and Dating	  	6
	Section 2.2	  	Execution and Authentication	  	8
	Section 2.3	  	Registrar and Paying Agent	  	8
	Section 2.4	  	Paying Agent to Hold Money and Notes in Trust	  	9
	Section 2.5	  	Holder Lists	  	9
	Section 2.6	  	Transfer and Exchange	  	9
	Section 2.7	  	Replacement Notes	  	14
	Section 2.8	  	Outstanding Notes; Determinations of Holders’ Action	  	15
	Section 2.9	  	Temporary Notes	  	15
	Section 2.10	  	Cancellation	  	16
	Section 2.11	  	Persons Deemed Owners	  	16
	Section 2.12	  	Defaulted Interest	  	16
	 Section 2.13
	  	CUSIP Numbers	  	16
	
	ARTICLE III REDEMPTION
			
	Section 3.1	  	Optional Redemption	  	16
	Section 3.2	  	Mandatory Redemption	  	17
	
	ARTICLE IV COVENANTS
			
	Section 4.1	  	Ownership of Material Subsidiary Stock	  	17
	Section 4.2	  	Limitation on Pledges, Encumbrances and Liens	  	18
	Section 4.3	  	Payment of Notes	  	18
	Section 4.4	  	Maintenance of Office or Agency	  	19
	Section 4.5	  	Reports	  	19
	Section 4.6	  	Compliance Certificate	  	20
	
	ARTICLE V SUCCESSORS
			
	Section 5.1	  	When the Company May Merge, Consolidate or Transfer Assets	  	20
	 Section 5.2
	  	Successor Corporation Substituted	  	20
	
	ARTICLE VI EVENTS OF DEFAULT
			
	Section 6.1	  	Events of Default	  	20
	Section 6.2	  	Acceleration	  	22
	 Section 6.3
	  	Other Remedies	  	22

  

 i 

	 Section 6.4
	  	Waiver of Defaults	  	23
	 Section 6.5
	  	Control by Majority	  	23
	 Section 6.6
	  	Limitation on Suits	  	23
	 Section 6.7
	  	Rights of Holders of Notes to Receive Payment	  	23
	 Section 6.8
	  	Collection Suit By Trustee	  	23
	 Section 6.9
	  	Trustee May File Proofs of Claim	  	24
	 Section 6.10
	  	Priorities	  	24
	 Section 6.11
	  	Undertaking for Costs	  	25
	
	 ARTICLE VII TRUSTEE

			
	 Section 7.1
	  	Duties of Trustee	  	25
	 Section 7.2
	  	Rights of Trustee	  	26
	 Section 7.3
	  	Individual Rights of Trustee	  	27
	 Section 7.4
	  	Trustee’s Disclaimer	  	27
	 Section 7.5
	  	Notice of Defaults	  	27
	 Section 7.6
	  	Reports by Trustee to Holders	  	27
	 Section 7.7
	  	Compensation and Indemnity	  	28
	 Section 7.8
	  	Replacement of Trustee	  	28
	 Section 7.9
	  	Successor Trustee by Merger, etc	  	29
	 Section 7.10
	  	Eligibility; Disqualification	  	29
	 Section 7.11
	  	Preferential Collection of Claims Against Company	  	30
	 Section 7.12
	  	Other Capacities	  	30
	
	 ARTICLE VIII LEGAL DEFEASANCE AND COVENANT DEFEASANCE

			
	 Section 8.1
	  	Option to Effect Legal Defeasance or Covenant Defeasance	  	30
	 Section 8.2
	  	Legal Defeasance and Discharge	  	30
	 Section 8.3
	  	Covenant Defeasance	  	31
	 Section 8.4
	  	Conditions to Legal or Covenant Defeasance	  	31
	 Section 8.5
	  	Deposited Money and Government Securities to be Held in Trust; Other Miscellaneous Provisions	  	32
	 Section 8.6
	  	Repayment to Company	  	33
	 Section 8.7
	  	Reinstatement	  	33
	
	 ARTICLE IX AMENDMENT, SUPPLEMENT AND WAIVER

			
	 Section 9.1
	  	Without Consent of Holders of Notes	  	33
	 Section 9.2
	  	With Consent of Holders of Notes	  	34
	 Section 9.3
	  	Compliance With Trust Indenture Act	  	35
	 Section 9.4
	  	Revocation and Effect of Consents	  	35
	 Section 9.5
	  	Notation on or Exchange of Notes	  	36
	 Section 9.6
	  	Trustee to Sign Amendments, etc	  	36
	
	 ARTICLE X MISCELLANEOUS

			
	 Section 10.1
	  	Trust Indenture Act Controls	  	36
	 Section 10.2
	  	Notices	  	36
	 Section 10.3
	  	Communication by Holders of Notes With Other Holders of Notes	  	37
	 Section 10.4
	  	Certificate and Opinion as to Conditions Precedent	  	37
	 Section 10.5
	  	Statements Required in Certificate or Opinion	  	38

  

 ii 

	 Section 10.6
	  	Rules by Trustee and Agents	  	38
	 Section 10.7
	  	No Personal Liability of Directors, Officers, Employees and Shareholders	  	38
	 Section 10.8
	  	Governing Law	  	38
	 Section 10.9
	  	No Adverse Interpretation of Other Agreements	  	38
	 Section 10.10
	  	Successors	  	38
	 Section 10.11
	  	Severability	  	39
	 Section 10.12
	  	Counterpart Originals	  	39
	 Section 10.13
	  	Table of Contents, Headings, etc	  	39

  

	 Exhibit A-1
	  	Form of Global Note
	 Exhibit A-2
	  	Form of Definitive Note
	 Exhibit B
	  	Form of Certificate of Transfer

  
  

 iii 

 CROSS-REFERENCE TABLE* 
  

	 Trust Indenture Act Section

	  	Indenture Section

	 310(a)(1)
	  	7.10
	   (a)(2)
	  	7.10
	   (a)(3)
	  	N.A.
	   (a)(4)
	  	N.A.
	   (a)(5)
	  	7.10
	   (b)
	  	7.10
	   (c)
	  	N.A.
	 311(a)
	  	7.11
	   (b)
	  	7.11
	   (c)
	  	N.A.
	 312(a)
	  	2.5
	   (b)
	  	10.3
	   (c)
	  	10.3
	 313(a)
	  	7.6
	   (b)(1)
	  	N.A.
	   (b)(2)
	  	7.6, 7.7
	   (c)
	  	7.6; 10.2
	   (d)
	  	7.6
	 314(a)(1-3)
	  	4.5
	   (a)(4)
	  	N.A.
	   (b)
	  	N.A.
	   (c)(1)
	  	10.4
	   (c)(2)
	  	10.4
	   (c)(3)
	  	N.A.
	   (d)
	  	N.A.
	   (e)
	  	10.5
	   (f)
	  	N.A.
	 315(a)
	  	7.1
	   (b)
	  	7.5; 10.2
	   (c)
	  	7.1
	   (d)
	  	7.1
	   (e)
	  	6.11
	 316(a)(last sentence)
	  	2.9
	   (a)(1)(A)
	  	6.5
	   (a)(1)(B)
	  	6.4
	   (a)(2)
	  	N.A.
	   (b)
	  	6.7
	   (c)
	  	2.12
	 317(a)(1)
	  	6.8
	   (a)(2)
	  	6.9
	   (b)
	  	2.4
	 318(a)
	  	10.1
	   (b)
	  	N.A.
	   (c)
	  	10.1

  

 iv 

 N.A. means not applicable. 

	*	 	This Cross-Reference Table is not part of the Indenture. 

  
  

 v 

  
 INDENTURE, dated as of June
6, 2003, between GREENPOINT FINANCIAL CORP., a Delaware corporation (the “Company”), and THE BANK OF NEW YORK, a New York banking corporation, as trustee (the “Trustee”). 
  
 The Company and the Trustee agree as follows for the equal and ratable
benefit of the registered holders (the “Holders”) of the Notes (as defined below): 
  
 ARTICLE I 
  
 DEFINITIONS AND
INCORPORATION BY REFERENCE 
  
 Section 1.1 Definitions.

  
 “Additional Notes” means the Company’s 3.20%
Senior Notes Due 2008 (other than the Initial Notes and the Exchange Notes) issued under this Indenture in accordance with Section 2.2 hereof. 
  
 “Affiliate” of any specified Person means any other Person directly or indirectly controlling or controlled by or under direct or indirect
common control with such specified Person. For purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control with”), as used
with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or otherwise;
provided that beneficial ownership of 20% or more of the voting securities of a Person shall be deemed to be control. 
  
 “Agent” means the Registrar or any Paying Agent, authenticating agent or securities custodian. 
  
 “Agent Members” has the meaning assigned to it in Section 2.1.

  
 “Applicable Procedures” means, with respect to any
transfer or exchange of or for beneficial interests in any Global Note, the rules and procedures of the Depositary that apply to such transfer or exchange. 
  
 “Authentication Order” means a written order of the Company, signed by two Officers of the Company, authenticating Notes for original issue.

  
 “Bankruptcy Law” means Title 11 of the United States
Code (11 U.S.C. §§ 101 et. seq.) or any similar federal or state law for the relief of debtors. 
  
 “Board of Directors” means the Board of Directors of the Company or any committee thereof duly authorized to act on behalf of such Board of
Directors. 
  
 “Board Resolution” means a copy of a
resolution certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board of Directors and to be in full force and effect on the date of such certification, and delivered to the Trustee. 
  
 “Business Day” means any day other than a Legal Holiday.

 “Capital Stock” means (i) in the case of a corporation, corporate stock, (ii) in the case of an
association or business entity, any and all shares, interests, participations, rights or other equivalents (however designated) of corporate stock, (iii) in the case of a partnership or limited liability company, partnership or membership interests
(whether general or limited) and (iv) any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distribution of assets of, the issuing Person. 
  
 “Company” has the meaning assigned to it in the preamble to this
Indenture. 
  
 “Company Order” means a written request
or order signed in the name of the Company by any two Officers. 
  
 “Consolidated Assets” means all assets owned directly by the Company or indirectly by the Company through any Subsidiary and reflected on the Company’s consolidated balance sheet prepared in accordance with GAAP. 

 
 “Corporate Trust Office of the Trustee” shall be at the address
of the Trustee specified in Section 10.2 hereof or such other address as to which the Trustee may give notice to the Company. 
  
 “Covenant Defeasance” has the meaning assigned to it in Section 8.3. 
  
 “Default” means any event that is, or with the passage of time or the giving of notice (or both) would be, an
Event of Default. 
  
 “Definitive Notes” means Notes
that are in the form of the Note attached hereto as Exhibit A-2. 
  
 “Depositary” means DTC and any successor thereto or nominee thereof. 
  
 “DTC” means The Depository Trust Company. 
  
 “Event of Default” has the meaning assigned to it in Section 6.1. 
  
 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 
  
 “Exchange Notes” means the Company’s 3.20% Senior Notes Due 2008, issued by the Company in connection with
the Exchange Offer pursuant to Section 2.6(i) hereof. 
  
 “Exchange Offer” means the offer that may be made pursuant to the Registration Rights Agreement by the Company to exchange the Exchange Notes for the Initial Notes. 
  
 “GAAP” means generally accepted accounting principles in the United States set forth in the opinions and
pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants, the statements and pronouncements of the Financial Accounting Standards Board and such other statements by such other entities (including
the SEC) as have been accepted by a significant segment of the accounting profession. 
  

 -2- 

 “Global Notes” means Notes that are in the form of the Note attached hereto as Exhibit A-1, and
to the extent that such Notes are required to bear the Legend required by Section 2.6, such Notes will be in the form of a 144A Global Note. 
  
 “Government Securities” means direct obligations of, or obligations guaranteed by, the United States of America, and the payment for which the
United States pledges its full faith and credit. 
  
 “GreenPoint Bank” means GreenPoint Bank, a New York chartered savings bank and a subsidiary of the Company headquartered in New York, New York. 
  
 “GreenPoint Mortgage Funding, Inc.” means GreenPoint Mortgage Funding, Inc., a New York corporation and a
subsidiary of the Company headquartered in Novato, California. 
  
 “Holder” has the meaning assigned to it in the preamble to this Indenture. 
  
 “Indebtedness” means, without duplication, (i) all obligations for borrowed money, (ii) all obligations evidenced by debentures, notes or other similar instruments, (iii) all obligations in respect of
letters of credit or bankers acceptances or similar instruments (or reimbursement obligations with respect thereto), (iv) all obligations to pay the deferred purchase price of property or services, except trade accounts payable arising in the
ordinary course of business, (v) all obligations as lessee which are capitalized in accordance with GAAP, and (vi) all Indebtedness of others guaranteed by the Company or any of its Subsidiaries or for which the Company or any of its Subsidiaries is
legally responsible or liable (whether by agreement to purchase indebtedness of, or to supply funds or to invest in, others). 
  
 “Indenture” means this Indenture, as amended or supplemented from time to time. 
  
 “Initial Notes” means the $350,000,000 aggregate Principal Amount of the Company’s 3.20% Senior Notes Due
2008 issued under this Indenture on the date hereof. 
  
 “Institutional Accredited Investor” means an institution that is an “accredited investor” as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act. 
  
 “Legal Defeasance” has the meaning assigned to it in Section 8.2.

  
 “Legal Holiday” means a Saturday, a Sunday or a day
on which banking institutions in The City of New York are authorized by law, regulation or executive order to remain closed. If a payment date is a Legal Holiday, payment may be made on the next succeeding day that is not a Legal Holiday, and no
interest shall accrue on such payment for the intervening period. 
  
 “Legend” means the legend appearing on the form of Note attached hereto as Exhibit A-2 setting forth the restrictions on transfer of the Notes. 
  
 “Letter of Transmittal” means the letter of transmittal to be prepared by the Company and sent to all Holders of
the Notes for use by such Holders in connection with the Exchange Offer. 
  

 -3- 

 “Lien” has the meaning assigned to it in Section 7.7. 
  
 “Material Subsidiary” means either of GreenPoint Bank or GreenPoint
Mortgage Funding, Inc. and any successors thereof. 
  
 “Notes” means the Initial Notes, the Exchange Notes and the Additional Notes, to the extent applicable. 
  
 “Officer” means, with respect to any Person, the Chairman of the Board, the Chief Executive Officer, the President, the Chief Operating Officer,
the Chief Financial Officer, the Treasurer, any Assistant Treasurer, the Controller, the Secretary or any Vice President of such Person. 
  
 “Officers’ Certificate” means, with respect to any Person, a certificate that meets the requirements of Section 10.5 hereof signed on
behalf of such Person by either the principal executive officer, the principal financial officer, the treasurer or the principal accounting officer of such Person and another Officer of such Person. 
  
 “144A Global Note” means a permanent Global Note in the form of the
Note attached hereto as Exhibit A-1 and that is deposited with and registered in the name of the Depositary, representing Notes sold in reliance on Rule 144A under the Securities Act. 
  
 “Opinion of Counsel” means a written opinion that meets the requirements of Section 10.5 hereof from legal counsel
who is reasonably acceptable to the Trustee. The counsel may be an employee of or counsel to the Company, or any Subsidiary of the Company. 
  
 “Paying Agent” has the meaning assigned to it in Section 2.3. 
  
 “Person” means any individual, corporation, partnership, limited liability company, joint venture, association,
joint-stock company, trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity. 
  
 “Principal Amount” means the amount of a Note as set forth on the face of the Note. 
  
 “QIB” means a qualified institutional buyer as defined in Rule
144A. 
  
 “Registrar” has the meaning assigned to it in
Section 2.3. 
  
 “Registration Rights Agreement” means
the Registration Rights Agreement, dated as of June 6, 2003, by and among the Company and the other parties named on the signature pages thereof, as such agreement may be amended, modified or supplemented from time to time. 
  
 “Responsible Officer,” when used with respect to the Trustee, means
any vice president, any assistant vice president, any senior trust officer or assistant trust officer, any trust officer, or any other officer associated with the corporate trust department of the Trustee customarily performing functions similar to
those performed by any of the above designated officers and also means, with respect to a particular corporate trust matter, any other officer to 
  

 -4- 

 whom such matter is referred because of such person’s knowledge of and familiarity with the particular subject.

  
 “Restricted Definitive Note” means a Definitive Note
required to bear the Legend. 
  
 “Restricted Global
Note” means a Global Note required to bear the Legend. 
  
 “Rule 144” means Rule 144 promulgated under the Securities Act. 
  
 “Rule 144A” means Rule 144A promulgated under the Securities Act. 
  
 “SEC” means the Securities and Exchange Commission. 
  
 “Securities Act” means the Securities Act of 1933, as amended. 
  
 “Special Interest Premium” means all moneys then owing pursuant to Section 2(e) of the Registration Rights
Agreement. 
  
 “Subsidiary” means, with respect to any
Person, (i) any corporation, association or other business entity of which more than 50% of the total voting power of shares of Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors,
managers or trustees thereof is at the time owned or controlled, directly or indirectly, by such Person, (ii) any partnership (a) the sole general partner or the managing general partner of which is such Person or an entity described in clause (i)
and related to such Person or (b) the only general partners of which are such Person or of one or more entities described in clause (i) and related to such Person (or any combination thereof) and (iii) any limited liability company of which more
than 50% of the total membership interests is at the time owned or controlled, directly or indirectly, by such Person. 
  
 “TIA” means the Trust Indenture Act of 1939 (15 U.S.C. §§ 77aaa-77bbbb) as in effect on the date on which this Indenture is qualified
under the TIA and, to the extent required by law, as amended. 
  
 “Trustee” means the party named as such above until a successor replaces it in accordance with the applicable provisions of this Indenture and thereafter means the successor serving hereunder. 
  
 “Unrestricted Definitive Note” means a Definitive Note that does
not bear and is not required to bear the Legend. 
  
 “Unrestricted Global Note” means a Global Note that does not bear and is not required to bear the Legend. 
  
 “Voting Stock” means outstanding shares of capital stock having voting power for the election of directors, whether at all times or only so long
as no senior class of stock has such voting power because of default in dividends or other default. 
  
 Section 1.2 Incorporation by Reference of Trust Indenture Act. Whenever this Indenture refers to a provision of the TIA, the provision is
incorporated by reference in and made 
  

 -5- 

 a part of this Indenture. All terms used in this Indenture that are defined by the TIA, defined by TIA reference to
another statute or defined by SEC rule under the TIA have the meanings so assigned to them. 
  
 Section 1.3 Rules of Construction. Unless the context otherwise requires: 
  
 (a) a term has the meaning assigned to it; 
  
 (b) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; 
  
 (c) “or” is not exclusive; 
  
 (d) words in the singular include the plural, and words in the plural include
the singular; 
  
 (e) references to sections of or rules under the
Securities Act shall be deemed to include substitute, replacement or successor sections or rules adopted by the SEC from time to time; 
  
 (f) the words “herein,” “hereof” and “hereunder” and other words of similar import refer to this Indenture as a whole and
not to any particular Article, Section or other subdivision; and 
  
 (g) headings are used for convenience of reference only and do not affect interpretation. 
  
 ARTICLE II 
  
 THE NOTES 
  
 Section 2.1 Form and Dating.

  
 (a) General. The Notes and the Trustee’s
certificate of authentication shall be substantially in the form of Exhibits A-1 and A-2, which are a part of this Indenture. The Notes may have notations, legends or endorsements required by law, stock exchange rule or usage (provided that any such
notation, legend or endorsement required by usage is in a form acceptable to the Company). The Company shall provide any such notations, legends or endorsements to the Trustee in writing. Each Note shall be dated the date of its authentication. The
terms and provisions contained in the Notes shall constitute, and are hereby expressly made, a part of this Indenture and the Company and the Trustee, by their execution and delivery of this Indenture, expressly agree to such terms and provisions
and to be bound thereby. However, to the extent any provision of any Note conflicts with the express provisions of this Indenture, the provisions of this Indenture shall govern and be controlling. 
  
 (b) Global Notes. Notes offered and sold within the United States to
QIBs in reliance on Rule 144A shall be issued initially in the form of a 144A Global Note, which shall be deposited with the Trustee at its Corporate Trust Office, as custodian for the Depositary, and 
  

 -6- 

 registered in the name of the Depositary or the nominee thereof, duly executed by the Company and authenticated by the
Trustee as hereinafter provided. The aggregate Principal Amount of any Global Note may from time to time be increased or decreased by adjustments made on the records of the Trustee and the Depositary as hereinafter provided. Any adjustment of the
aggregate Principal Amount of a Global Note to reflect the amount of any increase or decrease in the amount of outstanding Notes represented thereby shall be made by the Trustee in accordance with instructions given by the Holder thereof as required
by Section 2.6 hereof and shall be made on the records of the Trustee and the Depositary. 
  
 Each Global Note shall bear a legend in substantially the following form: 
  
 “THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY TRUST COMPANY (“DTC”) OR A NOMINEE OF DTC. THIS SECURITY
IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN DTC OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND NO TRANSFER OF THIS SECURITY (OTHER THAN A TRANSFER OF THIS SECURITY AS A WHOLE BY DTC
TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC) MAY BE REGISTERED EXCEPT IN LIMITED CIRCUMSTANCES. 
  
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF DTC TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY
CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED
REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.” 
  
 Neither any members of, or participants in, the Depositary (collectively, the
“Agent Members”) nor any other Persons on whose behalf Agent Members may act shall have any rights under this Indenture with respect to any Global Note held on their behalf by the Depositary or by the Trustee as the custodian for the
Depositary or under such Global Note, and the Depositary may be treated by the Company, the Trustee and any agent of the Company or the Trustee as the absolute owner and Holder of such Global Note for all purposes whatsoever. Notwithstanding the
foregoing, nothing herein shall prevent the Company, the Trustee or any agent of the Company or the Trustee from giving effect to any written certification, proxy or other authorization furnished by the Depositary or impair, as between the
Depositary, its Agent Members and any other Person on whose behalf an Agent Member may act, the operation of customary practices of such Persons governing the exercise of the rights of a holder of a beneficial interest in any Global Note.

  
 (c) Definitive Notes. Notes offered and sold in
reliance on any exception under the Securities Act other than Rule 144A will be issued in the form of Definitive Notes. 
  

 -7- 

 Except as provided in Sections 2.1(c) and 2.6, owners of beneficial interests in Global Notes will not be entitled to
receive physical delivery of Definitive Notes. 
  
 Section 2.2
Execution and Authentication. The Notes shall be executed on behalf of the Company by any Officer. The signature of the Officer on the Notes may be manual or facsimile. Notes bearing the manual or facsimile signatures of individuals who were
at the time of the execution of the Notes the proper Officers of the Company shall bind the Company, notwithstanding that such individuals or any of them have ceased to hold such offices prior to the authentication and delivery of such Notes or did
not hold such offices at the date of authentication of such Notes. 
  
 No Note shall be entitled to any benefit under this Indenture or be valid or obligatory for any purpose unless there appears on such Note a certificate of authentication substantially in the form provided for herein duly executed by the
Trustee by manual signature of an authorized signatory, and such certificate upon any Note shall be conclusive evidence, and the only evidence, that such Note has been duly authenticated and delivered hereunder. 
  
 The Trustee shall authenticate and deliver (i) Initial Notes for original
issue in an aggregate Principal Amount of up to $350,000,000 upon one or more Company Orders without any further action by the Company, (ii) Additional Notes from time to time for original issue in aggregate Principal Amounts specified by the
Company, and (iii) Exchange Notes from time to time for issue in exchange for a like Principal Amount of Initial Notes or Additional Notes. The aggregate Principal Amount of Notes outstanding at any time may not exceed the amount set forth in the
foregoing sentence, except as provided in Section 2.7. The Notes shall be issued only in registered form without coupons and only in denominations of $1,000 of Principal Amount and any integral multiple thereof. 
  
 Upon receipt of an Authentication Order and an Officers’ Certificate
(and, if requested pursuant to Section 10.4, an Opinion of Counsel) (i) certifying that a registration statement relating to the Exchange Offer is effective, (ii) certifying that the conditions precedent to the Exchange Offer have been met and (iii)
requesting that the Trustee authenticate the Exchange Notes in exchange for delivery of the Notes for cancellation, the Trustee shall authenticate an additional series of Notes in an aggregate Principal Amount not to exceed $350,000,000, or such
greater amount if there are any Additional Notes, for issuance in exchange for the Notes tendered for exchange pursuant to the Exchange Offer registered under the Securities Act, provided that any such Notes have been delivered to the Trustee for
cancellation and the Trustee has received an Officers’ Certificate from the Company authorizing such cancellation. 
  
 Section 2.3 Registrar and Paying Agent. The Company shall maintain an office or agency where Notes may be presented for registration of transfer or
for exchange (“Registrar”), and an office or agency where Notes may be presented for purchase or payment (“Paying Agent”). The Registrar shall keep a register of the Notes and of their transfer and exchange. The Company may have
one or more additional paying agents. The term Paying Agent includes any additional paying agent, including any named pursuant to Section 4.4. 
  
 The Company shall enter into an appropriate agency agreement with any Registrar or Paying Agent (in each case, if such person is a person other than the
Trustee). The 
  

 -8- 

 agreement shall implement the provisions of this Indenture that relate to such agent. The Company shall notify the
Trustee of the name and address of any such agent. If the Company fails to maintain a Registrar or Paying Agent, the Trustee shall act as such and shall be entitled to appropriate compensation therefor pursuant to Section 7.7. The Company or any
Subsidiary of the Company or an Affiliate of any of them may act as Paying Agent or Registrar. 
  
 The Company initially appoints the Trustee as Registrar and Paying Agent in connection with the Notes. The Trustee may resign from any or all of such appointments upon 30 days’ written notice to the Company.

  
 Section 2.4 Paying Agent to Hold Money and Notes in
Trust. Except as otherwise provided herein, prior to 10 a.m. (Eastern standard time) on each due date of payments in respect of any Note, the Company shall deposit with the Paying Agent a sum of money (in immediately available funds if deposited
on the due date) sufficient to make such payments when so becoming due. The Company shall require each Paying Agent (other than the Trustee) to agree in writing that the Paying Agent shall hold in trust for the benefit of the Holders or the Trustee
all money held by the Paying Agent for the making of payments in respect of the Notes and shall notify the Trustee of any default by the Company in making any such payment. At any time during the continuance of any such default, the Paying Agent
shall, upon the written request of the Trustee, forthwith pay to the Trustee all money so held in trust. If the Company, a Subsidiary of the Company or an Affiliate of any of them acts as Paying Agent, it shall segregate the money held by it as
Paying Agent and hold it as a separate trust fund. The Company at any time may require a Paying Agent to pay all money held by it to the Trustee and to account for any funds disbursed by it. Upon doing so, the Paying Agent shall have no further
liability for the money. 
  
 Section 2.5 Holder Lists. The
Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of the Holders. If the Trustee is not the Registrar, the Company shall cause to be furnished to the Trustee at
least semiannually on May 22 and November 21 a listing of the Holders dated within 15 days of the date on which the list is furnished and at such other times as the Trustee may request in writing a list in such form and as of such date as the
Trustee may reasonably require of the names and addresses of the Holders. 
  
 Section 2.6 Transfer and Exchange. 
  
 (a) Transfer and Exchange of Global Notes. A Global Note may not be transferred except by the Depositary to a nominee of the Depositary, by a nominee of the Depositary to the Depositary or to another nominee of
the Depositary, or by the Depositary or any such nominee to a successor Depositary or a nominee of such successor Depositary. All Global Notes will be exchanged by the Company for Definitive Notes if 
  
 (i) the Depositary has notified the Company that it is
unwilling or unable to continue as Depositary for such Global Note or such Depositary has ceased to be a “clearing agency” registered under the Exchange Act, and a successor depositary is not appointed by the Company within 90 days,

  

 -9- 

 (ii) the Company determines that the Notes are no longer to be represented by Global
Notes and so notifies the Trustee, or 
  
 (iii)
an Event of Default has occurred and is continuing with respect to the Notes. 
  
 Any Global Note exchanged pursuant to clause (i) or (ii) above shall be so exchanged in whole and not in part, and any Global Note exchanged pursuant to clause (iii) above may be exchanged in whole or from time to
time in part as directed by the Depositary. 
  
 Upon the
occurrence of either of the preceding events in (i), (ii) or (iii) above, Definitive Notes shall be issued in fully registered form, without interest coupons, shall have an aggregate Principal Amount equal to that of the Global Note or portion
thereof to be so exchanged, shall be registered in such names and be in such authorized denominations as the Depositary shall instruct the Trustee in writing and shall bear the Legend as provided herein. Global Notes also may be exchanged or
replaced, in whole or in part, as provided in Sections 2.7 and 2.9 hereof. Every Note authenticated and delivered in exchange for, or in lieu of, a Global Note or any portion thereof, pursuant to this Section 2.6 or Section 2.7 or 2.9 hereof, shall
be authenticated and delivered in the form of, and shall be, a Global Note, except as otherwise provided herein. A Global Note may not be exchanged for another Note other than as provided in this Section 2.6(a); however, beneficial interests in a
Global Note may be transferred and exchanged as provided in Section 2.6(b) or (i) hereof. 
  
 Any Global Note to be exchanged in whole shall be surrendered by the Depositary to the Trustee, as Registrar. With regard to any Global Note to be exchanged in part, either such Global Note shall be so surrendered for
exchange or, if the Trustee is acting as custodian for the Depositary or its nominee with respect to such Global Note, the Principal Amount thereof shall be reduced, by an amount equal to the portion thereof to be so exchanged, by means of an
appropriate adjustment made on the records of the Trustee. Upon any such surrender or adjustment, the Trustee shall authenticate and deliver the Note issuable on such exchange to or upon the order of the Depositary or an authorized representative
thereof. 
  
 (b) Transfer and Exchange of Beneficial Interests
in Global Notes. The transfer and exchange of beneficial interests in the Global Notes shall be effected through the Depositary in accordance with the Applicable Procedures. Beneficial interests in the Restricted Global Notes shall be subject to
restrictions on transfer comparable to those set forth herein with respect to transfers of Notes to the extent required by the Securities Act. 
  
 (c) Transfer and Exchange of Definitive Notes. When Definitive Notes are presented by a Holder to the Registrar with a request: 
  
 (i) to register the transfer of such Definitive Notes; or

  
 (ii) to exchange such Definitive Notes for an
equal Principal Amount of Definitive Notes of other authorized denominations, 
  

 -10- 

 the Registrar shall register the transfer or make the exchange as requested if its reasonable requirements for such
transaction are met; provided, however, that the Definitive Notes surrendered for transfer or exchange: 
  
 (A) shall be duly endorsed or accompanied by a written instrument of transfer in form reasonably satisfactory to the Company and the
Registrar, duly executed by the Holder thereof or such Holder’s attorney duly authorized in writing; and 
  
 (B) so long as such Notes are Restricted Definitive Notes, such Notes are being transferred or exchanged pursuant to an effective
registration statement under the Securities Act or pursuant to clause (1), (2) or (3) below, and are accompanied by the following additional information and documents, as applicable: 
  
 (1) if such Definitive Notes are being delivered to the Registrar by a Holder for registration in the name
of such Holder, without transfer, a certification from such Holder to that effect; or 
  
 (2) if such Definitive Notes are being transferred to the Company, a certification to that effect; or 
  
 (3) if such Definitive Notes are being transferred pursuant
to an exemption from registration (i) a certification to that effect (in the form set forth in Exhibit B, if applicable) and (ii) if so required by the Legend and if the Company or Registrar so requests, an Opinion of Counsel or other evidence
reasonably satisfactory to them as to the compliance with the restrictions set forth in the Legend. 
  
 (d) Restrictions on Transfer of a Definitive Note for a Beneficial Interest in a Global Note. A Definitive Note may not be exchanged for a
beneficial interest in a Global Note except upon satisfaction of the requirements set forth below. 
  
 Upon receipt by the Trustee of a Definitive Note, duly endorsed or accompanied by appropriate instruments of transfer, in form satisfactory to the
Trustee, together with: 
  
 (i) so long as the
Notes are Restricted Definitive Notes, certification, in the form set forth in Exhibit B, that such Definitive Note is being transferred to a QIB in accordance with Rule 144A; and 
  
 (ii) written instructions directing the Trustee to make, or to direct the Registrar to make, an adjustment
on its books and records with respect to such Global Note to reflect an increase in the aggregate Principal Amount of the Notes represented by the Global Note, such instructions to contain information regarding the Depositary account to be credited
with such increase, 
  
 the Trustee shall cancel such Definitive Note and cause,
or direct the Registrar to cause, in accordance with the standing instructions and procedures existing between the Depositary and 
  

 -11- 

 the Registrar, the aggregate Principal Amount of Notes represented by the Global Note to be increased by the aggregate
Principal Amount of the Definitive Note to be exchanged, and shall credit or cause to be credited to the account of the Person specified in such instructions a beneficial interest in the Global Note equal to the Principal Amount of the Definitive
Note so cancelled. If no Global Notes are then outstanding, the Company shall issue and the Trustee shall authenticate, upon written order of the Company in the form of an Officers’ Certificate, a new Global Note in the appropriate Principal
Amount. 
  
 (e) Restrictions on Transfer of Beneficial Interest
in a Global Note for a Definitive Note. A beneficial interest in a Global Note may not be exchanged for a Definitive Note except upon satisfaction of the requirements set forth below. 
  
 Upon receipt by the Trustee of: 
  
 (i) so long as the Notes are Restricted Global Notes, certification in the form set forth in Exhibit B, that such Restricted Note is being
transferred to an Institutional Accredited Investor; and 
  
 (ii) written instructions directing the Trustee to make, or to direct the Registrar to make, an adjustment on its books and records with respect to such Global Note to reflect a decrease in the aggregate Principal
Amount of the Notes represented by the Global Note, such instructions to contain information regarding the DTC account to be reduced by such decrease, 
  
 the Trustee shall deliver one or more new Definitive Notes and cause, or direct the Registrar to cause, in accordance with the standing instructions and
procedures existing between DTC and the Registrar, the aggregate Principal Amount of Notes represented by the Global Note to be decreased by the aggregate Principal Amount of the Global Notes to be exchanged, and shall deduct or cause to be deducted
from the account of the Person specified in such instructions a beneficial interest in the Global Note equal to the Principal Amount of the Global Note so transferred. 
  
 (f) Compliance with Restrictions on Transfer. Subject to the succeeding paragraph, every Note shall be subject to the
restrictions on transfer provided in the Legend including the delivery of an Opinion of Counsel, if so required. Whenever any Restricted Definitive Note or Restricted Global Note is presented or surrendered for registration of transfer or for
exchange for a Note registered in a name other than that of the Holder, such Note must be accompanied by a certificate in substantially the form set forth in Exhibit B, dated the date of such surrender and signed by the Holder of such Note, as to
compliance with such restrictions on transfer. The Registrar shall not be required to accept for such registration of transfer or exchange any Note not so accompanied by a properly completed certificate. 
  
 (g) Termination of Restrictions on Transfer. The restrictions imposed
by the Legend upon the transferability of any Note shall cease and terminate when such Note has been sold pursuant to an effective registration statement under the Securities Act or transferred in compliance with Rule 144 under the Securities Act
(or any successor provision thereto) or, if earlier, upon the expiration of the holding period applicable to sales thereof under Rule 144(k) under the Securities Act (or any successor provision). Any Note as to which such restrictions on 

 

 -12- 

 transfer shall have expired in accordance with their terms or shall have terminated may, upon a surrender of such Note
for exchange to the Registrar in accordance with the provisions of this Section 2.6 (accompanied, in the event that such restrictions on transfer have terminated by reason of a transfer in compliance with Rule 144 or any successor provision, by an
opinion of counsel having substantial experience in practice under the Securities Act and otherwise reasonably acceptable to the Company, addressed to the Company and in form acceptable to the Company, to the effect that the transfer of such Note
has been made in compliance with Rule 144 or such successor provision), be exchanged for a new Note, of like tenor and aggregate Principal Amount, which shall not bear the restrictive Legend. The Company shall inform the Trustee of the effective
date of any registration statement registering the Notes under the Securities Act. The Trustee shall not be liable for any action taken or omitted to be taken by it in good faith in accordance with the aforementioned opinion of counsel or
registration statement. 
  
 (h) Issuance of Notes with No
Legend; Removal of Legend. If Notes are issued upon the transfer, exchange or replacement of Notes subject to restrictions on transfer and bearing the Legend, or if a request is made to remove the Legend on a Note, the Notes so issued shall bear
the Legend, or the Legend shall not be removed, as the case may be, unless there is delivered to the Company and the Registrar such satisfactory evidence, which shall include an Opinion of Counsel, as may be reasonably required by the Company and
the Registrar, that such Notes are not “restricted” within the meaning of Rule 144 under the Securities Act and are freely tradeable under Rule 144(k). Upon (i) provision of such satisfactory evidence, or (ii) notification by the Company
to the Trustee and Registrar of the sale of such Note pursuant to a registration statement that is effective at the time of such sale, the Trustee, at the written direction of the Company, shall authenticate and deliver a Note that does not bear the
Legend. If the Legend is removed from the face of a Note and the Note is subsequently held by an Affiliate of the Company, the Legend shall be reinstated. 
  
 (i) Exchange Offer. Upon the occurrence of the Exchange Offer in accordance with the Registration Rights Agreement, the Company shall issue and,
upon receipt of an Authentication Order in accordance with Section 2.2, the Trustee shall authenticate (i) one or more Unrestricted Global Notes in an aggregate Principal Amount equal to the Principal Amount of the beneficial interests in the
Restricted Global Notes tendered for acceptance and accepted for exchange in the Exchange Offer, by Persons that certify in the Letters of Transmittal that (w) they are not broker-dealers tendering Notes acquired directly from the Company, (x) the
Notes to be exchanged for the Exchange Notes were acquired in the ordinary course of their business, (y) they are not engaged in and do not intend to engage in a distribution (within the meaning of the Securities Act) of the Exchange Notes and they
have no arrangement or understanding with any person to participate in a distribution of the Exchange Notes and (z) they are not Affiliates of the Company, and (ii) Unrestricted Definitive Notes in an aggregate Principal Amount equal to the
Principal Amount of the Restricted Definitive Notes tendered for acceptance by Persons that make the required certifications in the Letters of Transmittal and accepted for exchange in the Exchange Offer. Concurrently with the issuance of such Notes,
the Trustee shall cause the aggregate Principal Amount of the applicable Restricted Global Notes to be reduced accordingly, and the Company shall execute and the Trustee shall authenticate and (at the expense of the Company) deliver to the Persons
designated by the Holders of Restricted Definitive Notes so accepted Unrestricted Definitive Notes in the appropriate Principal Amount. 
  

 -13- 

 (j) Cancellation and/or Adjustment of Global Notes. At such time as all beneficial interests in a
particular Global Note have been exchanged for Definitive Notes or a particular Global Note has been repurchased or canceled in whole and not in part, each such Global Note shall be returned to or retained and canceled by the Trustee in accordance
with Section 2.10 hereof. At any time prior to such cancellation, if any beneficial interest in a Global Note is exchanged for or transferred to a Person who will take delivery thereof in the form of a beneficial interest in another Global Note or
for Definitive Notes, the Principal Amount of Notes represented by such Global Note shall be reduced accordingly by adjustments made on the records of the Trustee to reflect such reduction; and if the beneficial interest is being exchanged for or
transferred to a Person who will take delivery thereof in the form of a beneficial interest in another Global Note, such other Global Note shall be increased accordingly by adjustments made on the records of the Trustee to reflect such increase.

  
 (k) General Provisions Relating to Transfers and
Exchanges. 
  
 (i) To permit registrations of
transfers and exchanges of Notes, the Company shall execute and the Trustee shall authenticate Global Notes and Definitive Notes upon receipt of an Authentication Order in accordance with Section 2.2 hereof or upon receipt of a written request of
the Registrar. 
  
 (ii) The Company shall not
charge a service charge for any registration of transfer or exchange, but the Company may require payment of a sum sufficient to pay all taxes, assessments or other governmental charges that may be imposed in connection with the transfer or exchange
of the Notes from the Holder requesting such transfer or exchange. 
  
 (iii) Any Registrar appointed pursuant to Section 2.3 hereof shall provide to the Trustee such information as the Trustee may reasonably require in connection with the delivery by such Registrar of Notes upon transfer
or exchange of Notes. 
  
 (iv) No Registrar shall
be required to make registrations of transfer or exchange of Notes during any periods designated in the text of the Notes or in this Indenture as periods during which such registration of transfers and exchanges need not be made. 
  
 Section 2.7 Replacement Notes. If (a) any mutilated Note is
surrendered to the Trustee, or (b) the Company and the Trustee receive evidence to their satisfaction of the destruction, loss or theft of any Note, and there is delivered to the Company and the Trustee such Note or indemnity as may be required by
them to save each of them harmless, then, in the absence of notice to the Company or the Trustee that such Note has been acquired by a bona fide purchaser, the Company shall execute, and upon its written request the Trustee shall authenticate and
deliver, in exchange for any such mutilated Note or in lieu of any such destroyed, lost or stolen Note, a new Note of like tenor and Principal Amount, bearing a number not contemporaneously outstanding. 
  
 In case any such mutilated, destroyed, lost or stolen Note has become or is
about to become due and payable the Company in its discretion may, instead of issuing a new Note, pay such Note. 
  

 -14- 

 Upon the issuance of any new Notes under this Section, the Company may require the payment of a sum
sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the reasonable fees and expenses of the Trustee and the reasonable fees and disbursements of its counsel) connected
therewith. 
  
 Every new Note issued pursuant to this Section in
lieu of any mutilated, destroyed, lost or stolen Note shall constitute an original additional contractual obligation of the Company, whether or not the destroyed, lost or stolen Note shall be at any time enforceable by anyone, and shall be entitled
to all benefits of this Indenture equally and proportionately with any and all other Notes duly issued hereunder. 
  
 The provisions of this Section are exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement or
payment of mutilated, destroyed, lost or stolen Notes. 
  
 Section
2.8 Outstanding Notes; Determinations of Holders’ Action. Notes outstanding at any time are all the Notes authenticated by the Trustee except for those cancelled by it, those paid pursuant to Section 2.7, those delivered to it for
cancellation and those described in this Section 2.8 as not outstanding. A Note does not cease to be outstanding because the Company or an Affiliate thereof holds the Note; provided, however, that in determining whether the Holders of the
requisite Principal Amount of Notes have given or concurred in any request, demand, authorization, direction, notice, consent, amendment or waiver hereunder, Notes owned by the Company or any other obligor upon the Notes or any Affiliate of the
Company or such other obligor shall be disregarded and deemed not to be outstanding, except that, in determining whether the Trustee shall be protected in relying upon any such request, demand, authorization, direction, notice, consent, amendment or
waiver, only Notes which a Responsible Officer of the Trustee actually knows to be so owned shall be so disregarded. Subject to the foregoing, only Notes outstanding at the time of such determination shall be considered in any such determination
(including, without limitation, determinations pursuant to Articles 6 and 9). 
  
 If a Note is replaced pursuant to Section 2.7, it ceases to be outstanding unless the Trustee receives proof satisfactory to it that the replaced Note is held by a bona fide purchaser. 
  
 If the Paying Agent (other than the Company or its subsidiaries) holds, in
accordance with this Indenture, on maturity, money or securities, if permitted hereunder, sufficient to pay Notes payable on that date, then immediately after such maturity such Notes shall cease to be outstanding and interest and Special Interest
Premium, if any, on such Notes shall cease to accrue. 
  
 Section
2.9 Temporary Notes. Pending the preparation of definitive Notes, the Company may execute, and upon Company Order the Trustee shall authenticate and deliver, temporary Notes which are printed, lithographed, typewritten, mimeographed or
otherwise produced, in any authorized denomination, substantially of the tenor of the definitive Notes in lieu of which they are issued and with such appropriate insertions, omissions, substitutions and other variations as the officers executing
such Notes may determine, as conclusively evidenced by their execution of such Notes. 
  

 -15- 

 If temporary Notes are issued, the Company will cause definitive Notes to be prepared without
unreasonable delay. After the preparation of definitive Notes, the temporary Notes shall be exchangeable for definitive Notes upon surrender of the temporary Notes at the office or agency of the Company designated for such purpose pursuant to
Section 2.3, without charge to the Holder. Upon surrender for cancellation of any one or more temporary Notes the Company shall execute and the Trustee shall authenticate and deliver in exchange therefor a like Principal Amount of definitive Notes
of authorized denominations. Until so exchanged the temporary Notes shall in all respects be entitled to the same benefits under this Indenture as definitive Notes. 
  
 Section 2.10 Cancellation. All Notes surrendered for payment or registration of transfer or exchange shall, if
surrendered to any person other than the Trustee, be delivered to the Trustee and shall be promptly cancelled by it. The Company may at any time deliver to the Trustee for cancellation any Notes previously authenticated and delivered hereunder which
the Company may have acquired in any manner whatsoever, and all Notes so delivered shall be promptly cancelled by the Trustee. The Company may not issue new Notes to replace Notes it has paid or delivered to the Trustee for cancellation. No Notes
shall be authenticated in lieu of or in exchange for any Notes cancelled as provided in this Section, except as expressly permitted by this Indenture. All cancelled Notes held by the Trustee shall be disposed of by the Trustee in accordance with the
Trustee’s customary procedure. 
  
 Section 2.11 Persons
Deemed Owners. Prior to due presentment of a Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name such Note is registered as the owner of such Note for the
purpose of receiving payment of principal of, interest on and Special Interest Premium, if any, on the Note for all purposes whatsoever, whether or not such Note be overdue, and neither the Company, the Trustee nor any agent of the Company or the
Trustee shall be affected by notice to the contrary. 
  
 Section
2.12 Defaulted Interest. If the Company defaults in a payment of interest on the Notes, it shall pay the defaulted interest in any lawful manner plus, to the extent lawful, interest payable on the defaulted interest, to the Persons who are
Holders on a subsequent special record date, in each case at the rate provided in the Notes and Section 4.3 hereof. The Company shall notify the Trustee in writing of the amount of defaulted interest proposed to be paid on each Note and the date of
the proposed payment. The Company shall fix or cause to be fixed each such special record date and payment date, provided that no such special record date shall be less than 10 days prior to the related payment date for such defaulted interest. At
least 15 days before the special record date, the Company (or, upon the written request of the Company, the Trustee in the name and at the expense of the Company) shall mail or cause to be mailed to Holders a notice that states the special record
date, the related payment date and the amount of such interest to be paid. 
  
 Section 2.13 CUSIP Numbers. The Company may issue the Notes with one or more “CUSIP” numbers (if then generally in use), and will promptly notify the Trustee of any change in the CUSIP numbers. The
Trustee may use such numbers in any notice of redemption or exchange. Any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Notes or as contained in any notice of redemption, and that

  

 -16- 

 reliance may be placed only on the other identification numbers printed on the Notes and any such redemption shall not be
affected by any defect in or omission of such numbers. 
  
 In the
event that the Company shall issue and the Trustee shall authenticate any Additional Notes pursuant to this Indenture, the Company shall use its best efforts to obtain the same CUSIP number for such Additional Notes as is printed on the Notes
outstanding at such time; provided, however, that if any Additional Notes are determined, pursuant to an Opinion of Counsel, to be a different class of security than the Notes outstanding at such time for federal income tax purposes, the
Company may obtain a CUSIP number for such Additional Securities that is different from the CUSIP number printed on the Notes then outstanding. 
  
 ARTICLE III 
  
 REDEMPTION 
  
 Section 3.1 Optional Redemption. The Company may not redeem the Notes prior to their stated maturity. 
  
 Section 3.2 Mandatory Redemption. The Company shall not be required to make mandatory redemption or sinking fund payments with respect to the
Notes. 
  
 ARTICLE IV 
  
 COVENANTS 
  
 Section 4.1 Ownership of Material Subsidiary Stock. So long as any of the Notes are outstanding but subject to the
provisions of Article V hereof, the Company: 
  
 (a) will not, nor
will it permit any Material Subsidiary to, sell or otherwise dispose of any shares of, securities convertible into, or options, warrants or rights to subscribe for or purchase shares of, Voting Stock of any Material Subsidiary, nor will the Company
permit any Material Subsidiary to issue any shares of, or securities convertible into, or options, warrants or rights to subscribe for or purchase shares of, Voting Stock of any Material Subsidiary if, in each case, after giving effect to any such
transaction and to the issuance of the maximum number of shares of Voting Stock of such Material Subsidiary issuable upon the exercise of all such convertible securities, options, warrants or rights, the Company would cease to own, directly or
indirectly, at least 80% of the issued and outstanding Voting Stock of such Material Subsidiary; and 
  
 (b) will not permit any Material Subsidiary to: 
  
 (i) merge or consolidate with or into any corporation or other Person, unless the Company is the surviving corporation or Person, or
unless, upon consummation of the merger or consolidation, the Company will own, directly or indirectly, at least 80% of the surviving corporation’s issued and outstanding Voting Stock; or 
  
 (ii) lease, sell, assign or transfer all or substantially
all of its properties and assets to any corporation or other Person (other than the Company), unless, upon such 
  

 -17- 

 sale, assignment or transfer, the Company will own, directly or indirectly, at least 80% of the issued
and outstanding Voting Stock of that corporation or other Person. 
  
 Notwithstanding the foregoing, any such sale, assignment or transfer of securities, any such merger or consolidation or any such lease, sale, assignment or transfer of properties and assets shall not be prohibited if required (A) by any law
or any rule, regulation or order of any governmental agency or authority or (B) as a condition imposed by any law or any rule, regulation or order of any governmental agency or authority to the acquisition by the Company, directly or indirectly,
through purchase of stock or assets, merger, consolidation or otherwise, of any Person; provided, that, in the case of (B) only, after giving effect to such disposition and acquisition, (y) at least 80% of the issued and outstanding Voting
Stock of such Person will be owned, directly or indirectly, by the Company and (z) the Consolidated Assets of the Company immediately following such merger or consolidation or any such lease, sale, assignment or transfer will be at least equal to
70% of the Consolidated Assets of the Company immediately prior thereto; and nothing in this Section shall prohibit the Company or any Material Subsidiary from the sale or transfer of assets pursuant to any securitization transaction or the pledge
of any assets to secure borrowings incurred in the ordinary course of business, including, without limitation, deposit liabilities, mortgage escrow funds, reverse repurchase agreements, repurchase agreements, Federal Home Loan Bank advances,
recourse obligations incurred in connection with any Material Subsidiary’s lending activities and letters of credit. 
  
 Section 4.2 Limitation on Pledges, Encumbrances and Liens. For so long as any of the Notes are outstanding, the Company will not, nor will the
Company permit any Material Subsidiary to, create, assume, incur or suffer to be created, assumed or incurred or to exist, any pledge, encumbrance or lien, as security for indebtedness for borrowed money, upon any shares of Voting Stock of any
Material Subsidiary (or securities convertible into, or options, warrants or rights to subscribe for or purchase shares of that Voting Stock), directly or indirectly, without making effective provision whereby the Notes shall be equally and ratably
secured with any and all such indebtedness if, treating such pledge, encumbrance or lien as a transfer of the shares of, or securities convertible into or options, warrants or rights to subscribe for or purchase shares of, Voting Stock of the
Material Subsidiary subject thereto to the secured party and after giving effect to the issuance of the maximum number of shares of Voting Stock of the Material Subsidiary issuable upon the exercise of all such convertible securities, options,
warrants or rights, the Company would not continue to own at least 80% of the issued and outstanding Voting Stock of the Material Subsidiary. 
  
 Section 4.3 Payment of Notes. The Company shall pay or cause to be paid the principal of, interest on and Special Interest Premium, if any, on the
Notes on the dates and in the manner provided in the Notes. Principal, interest and Special Interest Premium, if any, shall be considered paid on the date due if the Paying Agent, if other than the Company or a Subsidiary thereof, holds as of 10:00
a.m. Eastern Time on the due date money deposited by the Company in immediately available funds and designated for and sufficient to pay all principal, interest and Special Interest Premium, if any, then due. The Company shall pay all the Special
Interest Premium, if any, in the same manner on the dates and in the amounts set forth in the Registration Rights Agreement. 
  

 -18- 

 The Company shall pay interest (including post-petition interest in any proceeding under any Bankruptcy
Law) on overdue principal from time to time on demand at the rate equal to 1% per annum in excess of the then applicable interest rate on the Notes to the extent lawful; it shall pay interest (including post-petition interest in any proceeding under
any Bankruptcy Law) on overdue installments of interest and Special Interest Premium, if any, (without regard to any applicable grace period) from time to time on demand at the same rate to the extent lawful. 
  
 Section 4.4 Maintenance of Office or Agency. The Company shall
maintain in New York, New York, an office or agency (which may be an office of the Trustee or an Affiliate of the Trustee or Registrar) where Notes may be surrendered for registration of transfer or for exchange and where notices and demands to or
upon the Company in respect of the Notes and this Indenture may be served. The Company shall give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency. If at any time the Company shall fail
to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee. 
  
 The Company may also from time to time designate one or more other offices or
agencies where the Notes may be presented or surrendered for any or all such purposes and may from time to time rescind such designations. The Company shall give prompt written notice to the Trustee of any such designation or rescission and of any
change in the location of any such other office or agency. 
  
 The
Company hereby designates the Corporate Trust Office of the Trustee as one such office or agency of the Company in accordance with Section 2.3. 
  
 Section 4.5 Reports. (a) The Company shall file with the Trustee, within 15 days after it files such annual and quarterly reports, information,
documents and other reports with the SEC, copies of its annual report and of the information, documents and other reports (or copies of such portions of any of the foregoing as the SEC may by rules and regulations prescribe) which the Company is
required to file with the SEC pursuant to Section 13 or section 15(d) of the Exchange Act. In the event the Company is at any time no longer subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, it shall continue to
provide the Trustee with reports containing substantially the same information as would have been required to be filed with the SEC had the Company continued to have been subject to such reporting requirements. In such event, such reports shall be
provided at the times the Company would have been required to provide reports had it continued to have been subject to such reporting requirements. The Company also shall comply with the other provisions of Section 314(a) of the TIA. Delivery of
such reports, information and documents to the Trustee is for informational purposes only and the Trustee’s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained
therein, including the Company’s compliance with any of its covenants hereunder (as to which the Trustee is entitled to conclusively rely exclusively on Officers’ Certificates). 
  
 (b) For so long as any Initial Notes remain outstanding, the Company shall furnish to the Holders and to Initial Notes
analysts and prospective investors, upon their request, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act. 
  

 -19- 

 Section 4.6 Compliance Certificate. (a) The Company will deliver to the Trustee on or before 120
days after the end of each fiscal year of the Company, commencing with the first fiscal year ending after the date hereof, so long as Notes are outstanding hereunder, an Officers’ Certificate stating that, in the course of the performance by
the signers of their duties as officers of the Company, they would normally have knowledge of any Default or Event of Default by the Company in the performance of any covenants contained herein, stating whether or not they have knowledge of any such
Default or Event of Default, the nature thereof and the action, if any, the Company intends to undertake as a result of such Default. 
  
 (b) The Company shall, so long as any of the Notes are outstanding, deliver to the Trustee, forthwith upon any Officer becoming aware of any Default or
Event of Default, an Officers’ Certificate specifying such Default or Event of Default and what action the Company is taking or proposes to take with respect thereto. 
  
 ARTICLE V 
  
 SUCCESSORS 
  
 Section 5.1 When the Company May Merge, Consolidate or Transfer Assets. The Company shall not merge or consolidate with or into any other Person
and the Company shall not sell, lease or convey, in a single transaction or in a series of transactions, all or substantially all of its assets to any Person, unless (1) the Company is the continuing corporation, or the successor corporation or the
Person that acquires all or substantially all of the Company’s assets is a corporation organized and existing under the laws of the United States or a state thereof or the District of Columbia and expressly assumes all the Company’s
obligations under the Notes and this Indenture or assumes such obligations as a matter of law, (2) immediately after giving effect to such merger, consolidation, sale, lease or conveyance, there is no Default or Event of Default hereunder and (3)
the Company delivers or causes to be delivered to the Trustee an Officers’ Certificate and Opinion of Counsel each stating that the merger, consolidation, sale, lease or conveyance complies with this Indenture. 
  
 Section 5.2 Successor Corporation Substituted. Upon any consolidation
or merger, or any sale, assignment, transfer, lease, conveyance or other disposition of all or substantially all of the assets of the Company in accordance with Section 5.1 hereof, the successor corporation formed by such consolidation or into or
with which the Company is merged or to which such sale, assignment, transfer, conveyance or other disposition is made shall succeed to, and be substituted for (so that from and after the date of such consolidation, merger, sale, conveyance or other
disposition, the provisions of this Indenture referring to the “Company” shall refer instead to the successor corporation and not to the Company), and may exercise every right and power of, the Company under this Indenture with the same
effect as if such successor Person had been named as the Company herein, and, thereupon, the Company shall be relieved of any further liability or obligation hereunder or under the Notes. 
  
 ARTICLE VI 
  
 EVENTS OF DEFAULT 
  
 Section 6.1 Events of Default. An “Event of Default” occurs if: 
  

 -20- 

 (a) the Company defaults in the payment of any installment of interest or Special Interest Premium, if
any, upon any of the Notes as and when the same shall become due and payable, and such default continues for a period of 30 days; 
  
 (b) the Company defaults in the payment of all or any part of the principal of any of the Notes as and when the same shall become due and payable either
at maturity, by declaration of acceleration of maturity or otherwise; 
  
 (c) the Company fails to perform any other covenant or agreement on the part of the Company contained in the Notes or in this Indenture and such failure continues for a period of 60 days after the date on which notice specifying such
failure, stating that such notice is a “Notice of Default” hereunder and demanding that the Company remedy the same, shall have been given, by registered or certified mail, to the Company by the Trustee, or to the Company and the Trustee
by the Holders of at least 25% in aggregate Principal Amount of the Notes at the time outstanding; 
  
 (d) (i) the Company defaults in the scheduled payment of principal, or interest of or on any Indebtedness in excess of $25,000,000 which constitutes an
event of default as defined in any instrument of the Company under which such Indebtedness is or may be issued, or by which such Indebtedness is or may be secured or evidenced, which event of default has resulted in the acceleration of such
Indebtedness, or (ii) any default occurring in payment of any such Indebtedness at final maturity (and after the expiration of any applicable grace periods); 
  
 (e) a court having jurisdiction in the premises shall enter a decree or order for relief in respect of the Company or any Material Subsidiary in an
involuntary case or proceeding under any applicable bankruptcy, insolvency, reorganization or other similar law now or hereafter in effect, or a decree or order adjudging the Company or any Material Subsidiary a bankrupt or insolvent, or approving
as properly filed a petition seeking reorganization, arrangement, adjustment, or composition of or in respect of the Company or any Material Subsidiary under any applicable federal or state law, or appointing a receiver, liquidator, assignee,
custodian, trustee, sequestrator or similar official of the Company or any Material Subsidiary or for any substantial part of its property or ordering the winding up or liquidation of its affairs, shall have been entered, and such decree or order
shall remain unstayed and in effect for a period of 90 consecutive days; or 
  
 (f) the Company or any Material Subsidiary shall commence a voluntary case or proceeding under any applicable federal or state bankruptcy, insolvency, reorganization or other similar law now or hereafter in effect or
any other case or proceeding to be adjudicated a bankrupt or insolvent, or consent to the entry of a decree or order for relief in an involuntary case or proceeding under any such law, or to the commencement of any bankruptcy or insolvency case or
proceeding against the Company or any Material Subsidiary, or the filing by the Company or any Material Subsidiary of a petition or answer to consent seeking reorganization or relief under any such applicable federal or state law, or the consent by
the Company or any Material Subsidiary to the filing of such petition or to the appointment of or the taking possession by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or any Material
Subsidiary or of any substantial part of its property, or the making by the Company or any Material Subsidiary of an assignment for the benefit of 
  

 -21- 

 creditors, or the taking of action by the Company or any Material Subsidiary in furtherance of any such action.

  
 Upon becoming aware of any Event of Default, the Company shall
promptly deliver to the Trustee a written statement specifying such Event of Default. 
  
 Section 6.2 Acceleration. If any Event of Default (other than an Event of Default specified in clause (e) or (f) of Section 6.1 hereof) occurs and is continuing, the Trustee or the Holders of at least 25% in
Principal Amount of the then outstanding Notes may declare the Principal Amount of all the Notes and interest and Special Interest Premium, if any, accrued thereon to be due and payable immediately by a notice in writing to the Company (and to the
Trustee if given by the Holders of the outstanding Notes). If an Event of Default specified in clause (e) or (f) of Section 6.1 hereof occurs, the principal of, interest accrued on and Special Interest Premium, if any, accrued on all outstanding
Notes shall be due and payable without further action or notice. 
  
 Holders of a majority in Principal Amount of the then outstanding Notes may direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of the Notes notice of any continuing Default or Event of Default in
accordance with Section 7.5 hereof. The Holders of a majority in aggregate Principal Amount of the then outstanding Notes by written notice to the Trustee may on behalf of the Holders of all of the Notes rescind an acceleration and its consequences
if the rescission would not conflict with any judgment or decree of a court of competent jurisdiction and if all existing Events of Default (except nonpayment of principal or interest or Special Interest Premium that has become due solely because of
the acceleration) have been cured or waived. No such rescission shall affect any subsequent Default or Event of Default or impair any right consequential thereto. 
  
 In case the Trustee shall have proceeded to enforce any right under this Indenture and such proceedings shall have been
discontinued or abandoned because of such rescission or annulment or for any other reason or shall have been determined adversely to the Trustee, then and in every such case the Company, the Trustee and the Holders shall be restored respectively to
their several positions and rights hereunder, and all rights, remedies and powers of the Company, the Trustee and the Holders shall continue as though no such proceeding had been taken. 
  
 Section 6.3 Other Remedies. If an Event of Default occurs and is continuing, the Trustee may pursue any available
remedy to collect the payment of principal of, interest on and Special Interest Premium, if any, on the Notes or to enforce the performance of any provision of the Notes or this Indenture. 
  
 The Trustee may maintain a proceeding even if it does not possess any of the
Notes or does not produce any of them in the proceeding. A delay or omission by the Trustee or any Holder of a Note in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or
acquiescence in the Event of Default. No remedy is exclusive of any other remedy. All remedies are cumulative to the extent permitted by law. 
  

 -22- 

 Section 6.4 Waiver of Defaults. Holders of a majority in aggregate Principal Amount of the then
outstanding Notes by written notice to the Trustee may on behalf of the Holders of all of the Notes waive an existing Default or Event of Default and its consequences hereunder, except a continuing Default or Event of Default in the payment of the
principal of, interest on or Special Interest Premium, if any, on the Notes. Upon any such waiver, such Default shall cease to exist, and any Event of Default arising therefrom shall be deemed to have been cured for every purpose of this Indenture;
but no such waiver shall extend to any subsequent or other Default or impair any right consequent thereon. 
  
 Section 6.5 Control by Majority. Holders of a majority in Principal Amount of the then outstanding Notes may direct the time, method and place of
conducting any proceeding for exercising any remedy available to the Trustee or exercising any trust or power conferred on it. However, the Trustee may refuse to follow any direction that conflicts with law or this Indenture or that the Trustee
determines may be unduly prejudicial to the rights of other Holders of Notes or that may involve the Trustee in personal liability. The Trustee may take any other action consistent with this Indenture relating to any such direction. 
  
 Section 6.6 Limitation on Suits. A Holder of a Note may pursue a
remedy with respect to this Indenture or the Notes only if and subject to Section 6.7 hereof: 
  
 (a) the Holder of a Note gives to the Trustee written notice of a continuing Event of Default; 
  
 (b) the Holders of at least 25% in Principal Amount of the then outstanding Notes make a written request to the Trustee to pursue the remedy; 

 
 (c) such Holders offer and, if requested, provide to the Trustee security
and indemnity satisfactory to the Trustee against any loss, liability or expense; 
  
 (d) the Trustee does not comply with the request within 60 days after receipt of the request and the offer and, if requested, the provision of security and indemnity; and 
  
 (e) the Holders of a majority in Principal Amount of the then outstanding
Notes do not give the Trustee a direction inconsistent with the request during such 60 day period. 
  
 A Holder of a Note may not use this Indenture to prejudice the rights of another Holder of a Note or to obtain a preference or priority over another
Holder of a Note. 
  
 Section 6.7 Rights of Holders of Notes to
Receive Payment. Notwithstanding any other provision of this Indenture, the right of any Holder of a Note to receive payment of principal of, interest on and Special Interest Premium, if any, on the Note, on or after the respective due dates
expressed in the Note, or to bring suit for the enforcement of any such payment on or after such respective dates, shall not be impaired or affected without the consent of such Holder. 
  
 Section 6.8 Collection Suit By Trustee. If an Event of Default specified in Section 6.1(a) or (b) occurs and is
continuing, the Trustee is authorized to recover judgment in its own name and as trustee of an express trust against the Company for the whole amount of 
  

 -23- 

 principal, interest and Special Interest Premium, if any, remaining unpaid on the Notes and interest on overdue principal
and, to the extent lawful, interest and such further amount as shall be sufficient to cover the costs and expenses of collection, including the reasonable compensation, fees, expenses, disbursements and advances of the Trustee, its agents and
counsel. 
  
 Section 6.9 Trustee May File Proofs of Claim.
The Trustee is authorized to file such proofs of claim and other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, fees, expenses, disbursements and
advances of the Trustee, its agents and counsel) and the Holders of the Notes allowed in any judicial proceedings relative to the Company (or any other obligor upon the Notes), its creditors or its property and shall be entitled and empowered to
collect, receive and distribute any money or other property payable or deliverable on any such claims and any custodian in any such judicial proceeding is hereby authorized by each Holder to make such payments to the Trustee, and in the event that
the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due to it for the compensation, fees, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other
amounts due the Trustee under or in connection with this Indenture. To the extent that the payment of any such compensation, fees, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee
under or in connection with this Indenture out of the estate in any such proceeding shall be denied for any reason, payment of the same shall be secured by a perfected, first priority Lien on, and shall be paid out of, any and all distributions,
dividends, money, securities and other properties that the Holders may be entitled to receive in such proceeding whether in liquidation or under any plan of reorganization or arrangement or otherwise, and such Lien in favor of a predecessor Trustee
shall be senior to the Lien in favor of the current Trustee. Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of reorganization, arrangement, adjustment
or composition affecting the Notes or the rights of any Holder, or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding. 
  
 Section 6.10 Priorities. If the Trustee collects any money or other property pursuant to this Article, it shall be
applied in the following order: 
  
 First: to the Trustee
(including any predecessor Trustee), its agents and attorneys for amounts due under Section 7.7 hereof, including payment of all compensation, fees, expenses and liabilities incurred, and all advances made, by the Trustee and the costs and expenses
of collection; 
  
 Second: to Holders of Notes for amounts due and
unpaid on the Notes for principal, interest and Special Interest Premium, if any, ratably, without preference or priority of any kind, according to the amounts due and payable on the Notes for principal, interest and Special Interest Premium, if
any, respectively; and 
  
 Third: to the Company or to such party
as a court of competent jurisdiction shall direct. 
  
 The Trustee
may fix a record date and payment date for any payment to Holders of Notes pursuant to this Section 6.10. 
  

 -24- 

 Section 6.11 Undertaking for Costs. In any suit for the enforcement of any right or remedy under
this Indenture or in any suit against the Trustee for any action taken or omitted by it as a Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and the court in
its discretion may assess reasonable costs, including reasonable attorneys’ fees, against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section does not
apply to a suit by the Trustee, a suit by a Holder of a Note pursuant to Section 6.7 hereof, or a suit by Holders of more than 10% in Principal Amount of the then outstanding Notes. 
  
 ARTICLE VII 
  
 TRUSTEE 
 Section 7.1 Duties of Trustee.

  
 (a) If an Event of Default has occurred and is continuing, the
Trustee shall exercise such of the rights and powers vested in it by this Indenture, and use the same degree of care and skill in its exercise, as a prudent person would exercise or use under the circumstances in the conduct of such person’s
own affairs. 
  
 (b) Except during the continuance of an Event of
Default: 
  
 (i) the duties of the Trustee shall
be determined solely by the express provisions of this Indenture and the Trustee need perform only those duties that are specifically set forth in this Indenture and no others, and no implied covenants or obligations shall be read into this
Indenture against the Trustee; and 
  
 (ii) in
the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the
requirements of this Indenture. However, the Trustee shall examine the certificates and opinions to determine whether or not they conform to the requirements of this Indenture but need not verify the accuracy of the contents thereof. 
  
 (c) The Trustee may not be relieved from liabilities for its own negligent
action, its own negligent failure to act, or its own willful misconduct, except that: 
  
 (i) this paragraph does not limit the effect of paragraph (b) of this Section; 
  
 (ii) the Trustee shall not be liable for any error of
judgment made in good faith by a Responsible Officer, unless it is proved that the Trustee was negligent in ascertaining the pertinent facts; and 
  
 (iii) the Trustee shall not be liable with respect to any action it takes or omits to take in good faith in accordance with a direction
received by it pursuant to Section 6.5 or 6.6 hereof. 
  

 -25- 

 (d) Whether or not therein expressly so provided, every provision of this Indenture that in any way
relates to the Trustee is subject to paragraphs (a), (b), (c), (e) and (f) of this Section. 
  
 (e) No provision of this Indenture shall require the Trustee to expend or risk its own funds or incur any liability. The Trustee shall be under no obligation to exercise any of its rights and powers under this
Indenture at the request or direction of any Holders, unless such Holders shall have offered and, if requested, provided to the Trustee security and indemnity satisfactory to it against any loss, liability or expense. 
  
 (f) The Trustee shall not be liable for interest on any money received by it
except as the Trustee may agree in writing with the Company. Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law. 
  
 Section 7.2 Rights of Trustee. (a) The Trustee may conclusively rely upon any document believed by it to be genuine
and to have been signed or presented by the proper Person. The Trustee need not investigate any fact or matter stated in the document, but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as
it may see fit, and if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to examine the books, records and premises of the Company reasonably relating to such facts or matters personally or by agent or
attorney. 
  
 (b) Whenever in the administration of this Indenture
the Trustee shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Trustee (unless other evidence be herein specifically prescribed) may rely upon an Officers’
Certificate, an Opinion of Counsel or both. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on such Officers’ Certificate or Opinion of Counsel. The Trustee may consult with counsel, and the
advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection from liability in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon. 
  
 (c) The Trustee may act through its attorneys and agents and shall not be
responsible for the misconduct or negligence of any agent appointed with due care. 
  
 (d) The Trustee shall not be liable for any action it takes or omits to take in good faith that it believes to be authorized or within the rights or powers conferred upon it by this Indenture. 
  
 (e) Unless otherwise specifically provided in this Indenture, any demand,
request, direction or notice from the Company shall be sufficient if signed by an Officer of the Company. 
  
 (f) No permissive right of the Trustee to act hereunder shall be construed as a duty. 
  
 (g) The Trustee may request that the Company deliver an Officers’ Certificate setting forth the names of individuals
and/or titles of officers authorized at such time to take 
  

 -26- 

 specified actions pursuant to this Indenture, which Officers’ Certificate may be signed by any person authorized to
sign an Officers’ Certificate, including any person specified as so authorized in any such certificate previously delivered and not superseded. 
  
 Section 7.3 Individual Rights of Trustee. The Trustee, in its individual or any other capacity, may become the owner or pledgee of Notes and may
otherwise deal with the Company or any Affiliate of the Company with the same rights it would have if it were not Trustee. However, in the event that the Trustee acquires any conflicting interest it must eliminate such conflict within 90 days, apply
to the SEC for permission to continue as trustee or resign. Any Agent may do the same with like rights and duties. The Trustee is also subject to Sections 7.10 and 7.11 hereof. 
  
 Section 7.4 Trustee’s Disclaimer. The Trustee shall not be responsible for and makes no representation as to the
validity or adequacy of this Indenture, the Notes or the Registration Rights Agreement; it shall not be accountable for the Company’s use of the proceeds from the Notes or any money paid to the Company or upon the Company’s direction under
any provision of this Indenture; it shall not be responsible for the use or application of any money received by any Paying Agent other than the Trustee, and it shall not be responsible for any statement or recital herein or any statement in the
Notes or any other document in connection with the sale of the Notes or pursuant to this Indenture other than its certificate of authentication. 
  
 Section 7.5 Notice of Defaults. If a Default or Event of Default occurs and is continuing and if the Trustee receives written notice thereof, the
Trustee shall (at the expense of the Company) mail to Holders of Notes a notice of the Default or Event of Default within 90 days after it occurs. Except in the case of a Default or Event of Default in payment of principal of, interest on or Special
Interest Premium, if any, on any Note, the Trustee may withhold the notice if and so long as a committee of its Responsible Officers in good faith determines that withholding the notice is in the interests of the Holders of the Notes. For purposes
of this Indenture, the Trustee shall not be deemed to have received notice of any Default (except a Default or Event of Default in payment of principal of, interest on or Special Interest Premium, if any, on any Note) unless a Responsible Officer of
the Trustee has received actual notice of such Default. 
  
 Section 7.6 Reports by Trustee to Holders. Within 60 days after each November 15 beginning with the November 15 following the date of this Indenture, and for so long as Notes remain outstanding, the Trustee shall (at the expense of
the Company) mail to the Holders of the Notes a brief report dated as of such reporting date that complies with Section 313(a) of the TIA (but if no event described in Section 313(a) of the TIA has occurred within the twelve months preceding the
reporting date, no report need be transmitted). The Trustee also shall comply with Section 313(b)(2) of the TIA. The Trustee shall also transmit by mail all reports as required by Section 313(c) of the TIA. 
  
 A copy of each report at the time of its mailing to the Holders of Notes
shall be mailed to the Company and filed with the SEC and each stock exchange on which the Notes are listed in accordance with Section 313(d) of the TIA. The Company shall promptly notify the Trustee when the Notes are listed on any stock exchange
and thereafter shall promptly file all reports with the SEC and such stock exchange as are required to be filed by the rules and regulations of the SEC and of such stock exchange. 
  

 -27- 

 Section 7.7 Compensation and Indemnity. The Company agrees to pay to the Trustee from time to time
compensation as agreed upon in writing by the Trustee and the Company, and, in the absence of any such agreement, reasonable compensation for its acceptance of this Indenture and services hereunder. The Trustee’s compensation shall not be
limited by any law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee promptly upon request for all reasonable expenses (including taxes, other than those based upon the income of the Trustee or arising from
the compensation of its personnel), disbursements and advances incurred or made by it in connection with providing services hereunder in addition to the compensation for its services. Such expenses shall include the compensation, disbursements and
expenses of the Trustee’s agents and reasonable fees and expenses of counsel. The Company shall indemnify the Trustee against any and all losses, liabilities or expenses incurred by it arising out of or in connection with the acceptance or
administration of its duties under this Indenture, including the costs and expenses of enforcing this Indenture against the Company (including this Section 7.7) and defending itself against any claim (whether asserted by the Company or any Holder or
any other Person) or liability in connection with, relating to, or arising out of (i) the exercise or performance of any of its powers or duties hereunder, or in connection herewith, and (ii) the validity, invalidity, adequacy or inadequacy of this
Indenture or the Notes, except to the extent any such loss, liability or expense may be attributable to its negligence or willful misconduct. The Trustee shall notify the Company promptly of any claim for which it intends to seek indemnity. Failure
by the Trustee to so notify the Company shall not relieve the Company of its obligations hereunder. The Company shall defend the claim and the Trustee shall cooperate in the defense. The Trustee may have separate counsel and the Company shall pay
the reasonable fees and expenses of such counsel except to the extent attributable to the Trustee’s negligence or wilful misconduct. The Company need not pay for any settlement made without its written consent, which consent shall not be
unreasonably withheld. 
  
 The obligations of the Company to the
Trustee under this Indenture shall survive the satisfaction and discharge of this Indenture. 
  
 To secure the Company’s payment obligations in this Section, the Trustee shall have a mortgage, pledge, lien, charge, security interest or encumbrance (each, a “Lien”) prior to the Notes on all money or
property held or collected by the Trustee, except that held in trust to pay principal and interest on particular Notes. 
  
 When the Trustee incurs expenses or renders services after an Event of Default specified in Section 6.1(e) or (f) hereof occurs, the expenses and the
compensation for the services (including the fees and expenses of its agents and counsel) are intended to constitute expenses of administration under any Bankruptcy Law. 
  
 The Trustee shall comply with the provisions of Section 313(b)(2) of the TIA to the extent applicable. 
  
 Section 7.8 Replacement of Trustee. A resignation or removal of the
Trustee and appointment of a successor Trustee shall become effective only upon the successor Trustee’s acceptance of appointment as provided in this Section. 
  

 -28- 

 The Trustee may resign in writing at any time and be discharged from the trust hereby created by so
notifying the Company. The Holders of Notes of a majority in Principal Amount of the then outstanding Notes may remove the Trustee by so notifying the Trustee and the Company in writing. The Company may by a Board Resolution remove the Trustee if:

  
 (a) the Trustee fails to comply with Section 7.10 hereof;

  
 (b) the Trustee is adjudged a bankrupt or an insolvent or an
order for relief is entered with respect to the Trustee under any Bankruptcy Law; 
  
 (c) a custodian or public officer takes charge of the Trustee or its property; or 
  
 (d) the Trustee becomes incapable of acting. 
  
 If the Trustee resigns or is removed or if a vacancy exists in the office of Trustee for any reason, the Company shall promptly appoint a successor
Trustee. 
  
 If a successor Trustee does not take office within 60
days after the retiring Trustee resigns or is removed, the retiring Trustee (at the Company’s expense), the Company, or the Holders of at least 10% in Principal Amount of the then outstanding Notes may petition any court of competent
jurisdiction for the appointment of a successor Trustee. 
  
 If
the Trustee, after receiving a written request to resign by any Holder of a Note who has been a bona fide Holder of a Note for at least six months, fails to comply with Section 7.10, such Holder of a Note may petition any court of competent
jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. 
  
 A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the Company. Thereupon, the resignation or removal of the retiring Trustee shall become effective, and the
successor Trustee shall have all the rights, powers and duties of the Trustee under this Indenture. The successor Trustee shall mail a notice of its succession to Holders of the Notes. The retiring Trustee shall promptly transfer all property held
by it as Trustee to the successor Trustee, provided all sums owing to the Trustee hereunder have been paid and subject to the Lien provided for in Section 7.7 hereof. Notwithstanding replacement of the Trustee pursuant to this Section 7.8, the
Company’s obligations under Section 7.7 hereof shall continue for the benefit of the retiring Trustee. 
  
 Section 7.9 Successor Trustee by Merger, etc. If the Trustee or any Agent consolidates, merges or converts into, or transfers all or substantially
all of its corporate trust business to, another corporation, the successor corporation without any further act shall be the successor Trustee or Agent, as the case may be. 
  
 Section 7.10 Eligibility; Disqualification. There shall at all times be a Trustee hereunder that is a corporation
organized and doing business under the laws of the United States of America or of any state thereof that is authorized under such laws to exercise corporate trustee power, that is subject to supervision or examination by federal or state authorities
and that together with its direct parent, if any, or in the case of a corporation included in a bank holding company system, its related bank holding company, has a combined capital and surplus of at 
  

 -29- 

 least $50 million as set forth in its most recent published annual report of condition. This Indenture shall always have
a Trustee who satisfies the requirements of Section 310(a)(1), (2) and (5) of the TIA. The Trustee is subject to Section 310(b) of the TIA. 
  
 Section 7.11 Preferential Collection of Claims Against Company. The Trustee is subject to Section 311(a) of the TIA, excluding any creditor
relationship listed in Section 311(b) of the TIA. A Trustee who has resigned or been removed shall be subject to Section 311(a) of the TIA to the extent indicated therein. 
  
 Section 7.12 Other Capacities. All references in this Indenture to the Trustee shall be deemed to refer to the
Trustee in its capacity as Trustee and in its capacities as any Agent, to the extent acting in such capacities, and every provision of this Indenture relating to the conduct or affecting the liability or offering protection, immunity or indemnity to
the Trustee shall be deemed to apply with the same force and effect to the Trustee acting in its capacity as any Agent. 
  
 ARTICLE VIII 
  
 LEGAL DEFEASANCE AND COVENANT DEFEASANCE 
  
 Section 8.1 Option to Effect Legal Defeasance or Covenant Defeasance. The Company may, at its option and at any time, elect to have either Section 8.2 or 8.3 hereof be applied to all outstanding Notes upon
compliance with the conditions set forth below in this Article VIII. 
  
 Section 8.2 Legal Defeasance and Discharge. Upon the Company’s exercise under Section 8.1 hereof of the option applicable to this Section 8.2, the Company shall, subject to the satisfaction of the conditions set forth in Section
8.4 hereof, be deemed to have been discharged from its obligations with respect to all outstanding Notes (hereinafter, “Legal Defeasance”). For this purpose, Legal Defeasance means that the Company shall be deemed to have paid and
discharged the entire Indebtedness represented by the outstanding Notes, which shall thereafter be deemed to be “outstanding” only for the purposes of Section 8.5 hereof and the other Sections of this Indenture referred to in (a) below,
and to have satisfied all its other obligations under such Notes and this Indenture (and the Trustee, on demand of and at the expense of the Company, shall execute proper instruments acknowledging the same), except for the following provisions which
shall survive until otherwise terminated or discharged hereunder: (a) the rights of Holders of outstanding Notes to receive solely from the trust fund described in Section 8.4 hereof, and as more fully set forth in such Section, payments in respect
of the principal of, interest and Special Interest Premium, if any, on such Notes when such payments are due, (b) the Company’s obligations with respect to such Notes under Article II and Section 4.4 hereof, (c) the rights, powers, trusts,
duties and immunities of the Trustee and any Agent hereunder and the Company’s obligations in connection therewith, including, without limitation, Article VII and Section 8.5 and 8.7 hereunder, and (d) this Article VIII. Subject to compliance

  

 -30- 

 with this Article VIII, the Company may exercise its option under this Section 8.2 notwithstanding the prior exercise of
its option under Section 8.3 hereof. 
  
 Section 8.3 Covenant
Defeasance. Upon the Company’s exercise under Section 8.1 hereof of the option applicable to this Section 8.3, the Company shall, subject to the satisfaction of the conditions set forth in Section 8.4 hereof, be released from its
obligations under the covenants contained in Sections 4.1, 4.2, 4.5 and 4.6 hereof, under Section 6.1(c) hereof with respect to such covenants, and under Section 6.1 (d), (e) and (f) hereof with respect to the outstanding Notes on and after the date
the conditions set forth in Section 8.4 are satisfied (hereinafter, “Covenant Defeasance”), and the Notes shall thereafter be deemed not “outstanding” for the purposes of any direction, waiver, consent or declaration or act of
Holders (and the consequences of any thereof) in connection with such covenants, but shall continue to be deemed “outstanding” for all other purposes hereunder (it being understood that such Notes shall not be deemed outstanding for
accounting purposes). For this purpose, Covenant Defeasance means that, with respect to the outstanding Notes, the Company may omit to comply with and shall have no liability in respect of any term, condition or limitation set forth in any such
covenant, whether directly or indirectly, by reason of any reference elsewhere herein to any such covenant or by reason of any reference in any such covenant to any other provision herein or in any other document and such omission to comply shall
not constitute a Default or an Event of Default under Section 6.1 hereof, but, except as specified above, the remainder of this Indenture and such Notes shall be unaffected thereby. In addition, upon the Company’s exercise under Section 8.1
hereof of the option applicable to this Section 8.3 hereof, subject to the satisfaction of the conditions set forth in Section 8.4 hereof, Sections 6.1(d) through 6.1(f) hereof shall not constitute Events of Default. 
  
 Section 8.4 Conditions to Legal or Covenant Defeasance. The following
shall be the conditions to the application of either Section 8.2 or 8.3 hereof to the outstanding Notes: 
  
 In order to exercise either Legal Defeasance or Covenant Defeasance: 
  
 (a) the Company must irrevocably deposit with the Trustee, in trust, for the benefit of the Holders of the Notes, cash in
United States dollars, non-callable Government Securities, or a combination thereof, in such amounts as will be sufficient, in the opinion of a nationally recognized firm of independent public accountants, to pay the principal of, and interest on
the outstanding Notes on the stated maturity and the Company must specify the Notes are being defeased to maturity; 
  
 (b) in the case of an election under Section 8.2 hereof, the Company shall have delivered to the Trustee an Opinion of Counsel in the United States
reasonably acceptable to the Trustee confirming that (A) the Company has received from, or there has been published by, the Internal Revenue Service a ruling or (B) since the date of this Indenture, there has been a change in the applicable federal
income tax law, in either case to the effect that, and based thereon such Opinion of Counsel shall confirm that, the Holders of the outstanding Notes will not recognize income, gain or loss for federal income tax purposes as a result of such Legal
Defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Legal Defeasance had not occurred; 
  

 -31- 

 (c) the Company shall have delivered to the Trustee an Opinion of Counsel in the United States reasonably
acceptable to the Trustee confirming that, among other things, the defeasance trust does not constitute an “investment company” within the meaning of the Investment Company Act of 1940, as amended; 
  
 (d) in the case of an election under Section 8.3 hereof, the Company shall
have delivered to the Trustee an Opinion of Counsel in the United States reasonably acceptable to the Trustee confirming that, subject to customary assumptions and exclusions, the Holders of the outstanding Notes will not recognize income, gain or
loss for federal income tax purposes as a result of such Covenant Defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Covenant Defeasance had not
occurred; 
  
 (e) the Company shall have delivered to the Trustee
an Opinion of Counsel to the effect that (subject to customary qualifications and assumptions) after the 123rd day following the deposit, the trust funds will not be subject to the effect of any applicable bankruptcy, insolvency, reorganization or
similar laws affecting creditors’ rights generally; 
  
 (f)
no Default or Event of Default shall have occurred and be continuing on the date of such deposit or, insofar as Sections 6.1(e) or 6.1(f) hereof are concerned, at any time in the period ending on the 123rd day after the date of deposit; 

 
 (g) such Legal Defeasance or Covenant Defeasance shall not result in a
breach or violation of, or constitute a default under, any material agreement or instrument (other than this Indenture) to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound;

  
 (h) the Company shall have delivered to the Trustee an
Officers’ Certificate and an Opinion of Counsel, each stating that, subject to customary assumptions and exclusions, all conditions precedent provided for or relating to the Legal Defeasance or the Covenant Defeasance have been complied with;
and 
  
 (i) the Trustee shall have received such other documents,
assurances and Opinions of Counsel as the Trustee shall have reasonably required. 
  
 Section 8.5 Deposited Money and Government Securities to be Held in Trust; Other Miscellaneous Provisions. Subject to Section 8.6 hereof, all money and non-callable Government Securities (including the proceeds
thereof) deposited with the Trustee (or other qualifying trustee, collectively for purposes of this Section 8.5, the “Trustee”) pursuant to Section 8.4 hereof in respect of the outstanding Notes shall be held in trust and applied by the
Trustee, in accordance with the provisions of such Notes and this Indenture, to the payment, either directly or through any Paying Agent (including the Company acting as Paying Agent), to the Holders of such Notes of all sums due and to become due
thereon in respect of principal, and interest, but such money need not be segregated from other funds except to the extent required by law. 
  
 The Company agrees to pay and indemnify the Trustee against any tax, fee or other charge imposed on or assessed against the cash or non-callable
Government Securities 
  

 -32- 

 deposited pursuant to Section 8.4 hereof or the principal and interest received in respect thereof other than any such
tax, fee or other charge which by law is for the account of the Holders of the outstanding Notes. 
  
 Anything in this Article VIII to the contrary notwithstanding, the Trustee shall deliver or pay to the Company from time to time upon the written request
of the Company any money or non-callable Government Securities held by it as provided in Section 8.4 hereof which, in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof
delivered to the Trustee (which may be the opinion delivered under Section 8.4(a) hereof), are in excess of the amount thereof that would then be required to be deposited to effect an equivalent Legal Defeasance or Covenant Defeasance. 

 
 Section 8.6 Repayment to Company. Any money deposited with the
Trustee or any Paying Agent, or then held by the Company in trust for the payment of the principal of, or interest on any Note and remaining unclaimed for two years after such principal, or interest has become due and payable shall be paid to the
Company on its request or (if then held by the Company) shall be discharged from such trust; and the Holder of such Note shall thereafter, as a creditor, look only to the Company for payment thereof, and all liability of the Trustee or such Paying
Agent with respect to such trust money, and all liability of the Company as trustee thereof, shall thereupon cease; provided, however, that the Trustee or such Paying Agent, before being required to make any such repayment, may at the expense
of the Company cause to be published once in The New York Times and The Wall Street Journal (national edition), notice that such money remains unclaimed and that after a date specified therein, which shall not be less than 30 days from
the date of such notification or publication, any unclaimed balance of such money then remaining will be repaid to the Company. 
  
 Section 8.7 Reinstatement. If the Trustee or Paying Agent is unable to apply any United States dollars or non-callable Government Securities in
accordance with Section 8.2 or 8.3 hereof, as the case may be, by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, then the Company’s obligations under this
Indenture and the Notes shall be revived and reinstated as though no deposit had occurred pursuant to Section 8.2 or 8.3 hereof until such time as the Trustee or Paying Agent is permitted by such court or governmental authority to apply all such
money in accordance with Section 8.2 or 8.3 hereof, as the case may be; provided, however, that, if the Company makes any payment of principal of, or interest on any Note following the reinstatement of its obligations, the Company shall be
subrogated to the rights of the Holders of such Notes to receive such payment from the money held by the Trustee or Paying Agent. 
  
 ARTICLE IX 
  
 AMENDMENT, SUPPLEMENT AND WAIVER 
  
 Section 9.1 Without Consent of Holders of Notes. Notwithstanding Section 9.2 of this Indenture, the Company and the Trustee may amend or supplement this Indenture or the Notes without the consent of any Holder
of a Note: 
  
 (a) to cure any ambiguity, defect or inconsistency;

  

 -33- 

 (b) to provide for uncertificated Notes in addition to or in place of Definitive Notes or to alter the
provisions of Article II hereof (including the related definitions) in a manner that does not adversely affect any Holder; 
  
 (c) to provide for the assumption of the Company’s obligations to the Holders of the Notes by a successor to the Company pursuant to Article V
hereof; 
  
 (d) to make any change that would provide any
additional rights or benefits to the Holders of the Notes; 
  
 (e)
to make any change that is not inconsistent with this Indenture and does not adversely affect the legal rights hereunder of any Holder of the Notes; or 
  
 (f) to comply with requirements of the SEC in order to effect or maintain the qualification of this Indenture under the TIA. 
  
 Upon the request of the Company accompanied by a Board Resolution authorizing
the execution of any such amended or supplemental Indenture, and upon receipt by the Trustee of the documents described in Sections 7.2 and 9.6 hereof, the Trustee shall join with the Company in the execution of any amended or supplemental Indenture
authorized or permitted by the terms of this Indenture and make any further appropriate agreements and stipulations that may be therein contained, but the Trustee shall not be obligated to enter into such amended or supplemental Indenture that
affects its own rights, duties or immunities under this Indenture or otherwise. 
  
 Section 9.2 With Consent of Holders of Notes. Except as provided below in this Section 9.2, the Company and the Trustee may amend or supplement this Indenture and the Notes with the consent of the Holders of at
least a majority in Principal Amount of the Notes then outstanding voting as a single class (including, without limitation, consents obtained in connection with a purchase of, or tender offer or exchange offer for the Notes), and, subject to
Sections 6.4, 6.6 and 6.7 hereof, any existing Default or Event of Default (other than a Default or Event of Default in the payment of the principal of, interest on or Special Interest Premium, if any, on the Notes, except a payment default
resulting from an acceleration that has been rescinded) may be waived with the consent of the Holders of a majority in Principal Amount of the then outstanding Notes voting as a single class (including consents obtained in connection with a tender
offer or exchange offer for, or purchase of, the Notes). Section 2.8 hereof shall determine which Notes are considered to be “outstanding” for purposes of this Section 9.2. 
  
 Upon the request of the Company accompanied by a Board Resolution authorizing the execution of any such amended or
supplemental Indenture, and upon receipt by the Trustee of evidence satisfactory to the Trustee of the consent of the Holders of Notes as aforesaid, and upon receipt by the Trustee of the documents described in Sections 7.2 and 9.6 hereof, the
Trustee shall join with the Company in the execution of such amended or supplemental Indenture unless such amended or supplemental Indenture directly affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise, in
which case the Trustee may, but shall not be obligated to, enter into such amended or supplemental Indenture. 
  

 -34- 

 It shall not be necessary for the consent of the Holders of Notes under this Section 9.2 to approve the
particular form of any proposed amendment or waiver, but it shall be sufficient if such consent approves the substance thereof. 
  
 After an amendment, supplement or waiver under this Section becomes effective, the Company shall mail to the Holders of Notes affected thereby a notice
briefly describing the amendment, supplement or waiver. Any failure of the Company to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such amended or supplemental Indenture or waiver.

  
 Subject to Sections 6.4, 6.6 and 6.7 hereof, the Holders of a
majority in aggregate Principal Amount of the Notes then outstanding voting as a single class may waive compliance in a particular instance by the Company with any provision of this Indenture or the Notes. However, without the consent of each Holder
affected, an amendment or waiver under this Section 9.2 may not (with respect to any Notes held by a non-consenting Holder): 
  
 (a) change the stated maturity of the principal of, installment of interest on or Special Interest Premium, if any, on any Note; 
  
 (b) reduce the Principal Amount of, reduce the rate of, or extend or change
the time for payment of interest on, any Note; 
  
 (c) change the
place or currency of payment of principal of, interest on or Special Interest Premium, if any, on any Note; 
  
 (d) impair the right to institute suit for the enforcement of any payment on or with respect to any Note; 
  
 (e) reduce the percentage in Principal Amount of outstanding Notes the
consent of whose Holders is required for modification or amendment of this Indenture; 
  
 (f) reduce the percentage in Principal Amount of outstanding Notes necessary for waiver of compliance with certain provisions of this Indenture or for waiver of certain Defaults; or 
  
 (g) modify such provisions with respect to modification and waiver.

  
 Section 9.3 Compliance With Trust Indenture Act. Every
amendment or supplement to this Indenture or the Notes shall be set forth in an amended or supplemental Indenture that complies with the TIA as then in effect. 
  

Section 9.4 Revocation and Effect of Consents. Until an amendment, supplement or waiver becomes effective, a consent to it by a Holder is a
continuing consent by the Holder and every subsequent Holder of a Note or portion of a Note that evidences the same debt as the consenting Holder’s Note, even if notation of the consent is not made on any Note. However, any such Holder or
subsequent Holder may revoke the consent as to its Note if the Trustee receives written notice of revocation before the date the waiver, supplement or 
  

 -35- 

 amendment becomes effective. An amendment, supplement or waiver becomes effective in accordance with its terms and
thereafter binds every Holder. 
  
 Section 9.5 Notation on or
Exchange of Notes. The Trustee may place an appropriate notation about an amendment, supplement or waiver on any Note thereafter authenticated. The Company in exchange for all Notes may issue and the Trustee shall, upon receipt of an
Authentication Order, authenticate new Notes that reflect the amendment, supplement or waiver. 
  
 Failure to make the appropriate notation or issue a new Note shall not affect the validity and effect of such amendment, supplement or waiver. 
  
 Section 9.6 Trustee to Sign Amendments, etc. The Trustee shall sign any amended or supplemental Indenture authorized
pursuant to this Article IX if the amendment or supplement does not adversely affect the rights, duties, liabilities or immunities of the Trustee. The Company may not sign an amendment or supplemental Indenture until the Board of Directors approves
it. In executing any amended or supplemental Indenture, the Trustee shall be entitled to receive and (subject to Section 7.1 hereof) shall be fully protected in relying upon, in addition to the documents required by Section 10.4 hereof, an
Officers’ Certificate and an Opinion of Counsel stating that the execution of such amended or supplemental Indenture is authorized or permitted by this Indenture. 
  
 ARTICLE X 
  
 MISCELLANEOUS 
  
 Section 10.1 Trust Indenture Act Controls. If any provision of this Indenture limits, qualifies or conflicts with the duties imposed by Section
318(c) of the TIA, the duties imposed by Section 318(c) of the TIA shall control. 
  
 Section 10.2 Notices. Any notice or communication by the Company or the Trustee to the other is duly given if in writing and delivered in person or mailed by first class mail (registered or certified, return
receipt requested), telex, telecopier or overnight air courier guaranteeing next day delivery, to the other’s address set forth below: 
  
 If to the Company: 
  
 GreenPoint Financial Corp. 
 90 Park Avenue 
 New York, New York 10016 
 Attention: Howard C. Bluver, Esq. 
 Facsimile: (212) 834-1404 
  
 and 
  

 -36- 

 Wachtell, Lipton, Rosen & Katz 
 51 West 52nd Street 
 New York, New York 10019 
 Attention: Craig Wasserman, Esq. 
 Facsimile: (212) 403-2232 
  
 If
to the Trustee: 
  
 The Bank of New York

 101 Barclay Street 
 Floor 8W 
 New York, New York 10286 
 Attention: Corporate Trust Administration 
 Facsimile: (212) 875-5704 
  
 The
Company or the Trustee, by notice to the other, may designate additional or different addresses for subsequent notices or communications. All notices and communications (other than those sent to Holders) shall be deemed to have been duly given: at
the time delivered by hand, if personally delivered; five Business Days after being deposited in the mail, postage prepaid, if mailed; when answered back, if telexed; when receipt acknowledged, if telecopied; and the next Business Day after timely
delivery to the courier, if sent by overnight air courier guaranteeing next day delivery. Any notice or communication to a Holder shall be mailed by first class mail, certified or registered, return receipt requested, or by overnight air courier
guaranteeing next day delivery to its address shown on the register kept by the Registrar. Any notice or communication shall also be so mailed to any Person described in Section 313(c) of the TIA, to the extent required by the TIA. Failure to mail a
notice or communication to a Holder or any defect in it shall not affect its sufficiency with respect to other Holders. 
  
 If a notice or communication is mailed in the manner provided above within the time prescribed, it is duly given, whether or not the addressee receives
it, except for notices or communications to the Trustee, which shall be effective only upon actual receipt thereof. 
  
 If the Company mails a notice or communication to Holders, it shall mail a copy to the Trustee and each Agent at the same time. 
  
 Section 10.3 Communication by Holders of Notes With Other Holders of
Notes. Holders may communicate pursuant to Section 312(b) of the TIA with other Holders with respect to their rights under this Indenture or the Notes. The Company, the Trustee, the Registrar and anyone else shall have the protection of Section
312(c) of the TIA. 
  
 Section 10.4 Certificate and Opinion as
to Conditions Precedent. Upon any request or application by the Company to the Trustee to take any action under this Indenture, the Company shall furnish to the Trustee: 
  
 (a) an Officers’ Certificate in form and substance reasonably satisfactory to the Trustee (which shall include the
statements set forth in Section 10.5 hereof) stating that, in the opinion of the signers, all conditions precedent and covenants, if any, provided for in this Indenture relating to the proposed action have been satisfied; and 
  

 -37- 

 (b) an Opinion of Counsel in form and substance reasonably satisfactory to the Trustee (which shall
include the statements set forth in Section 10.5 hereof) stating that, in the opinion of such counsel, all such conditions precedent and covenants have been satisfied. 
  
 Section 10.5 Statements Required in Certificate or Opinion. Each certificate or opinion with respect to compliance
with a condition or covenant provided for in this Indenture (other than a certificate provided pursuant to Section 314(a)(4) of the TIA) shall comply with the provisions of Section 314(e) of the TIA and shall include: 
  
 (a) a statement that the Person making such certificate or opinion has read
such covenant or condition; 
  
 (b) a brief statement as to the
nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based; 
  
 (c) a statement that, in the opinion of such Person, he or she has made such examination or investigation as is necessary to enable him or her to express
an informed opinion as to whether or not such covenant or condition has been satisfied; and 
  
 (d) a statement as to whether or not, in the opinion of such Person, such condition or covenant has been satisfied. 
  
 Section 10.6 Rules by Trustee and Agents. The Trustee may make reasonable rules for action by or at a meeting of Holders. The Registrar or Paying
Agent may make reasonable rules and set reasonable requirements for its functions. 
  
 Section 10.7 No Personal Liability of Directors, Officers, Employees and Shareholders. No director, officer, employee, incorporator or stockholder of the Company, as such, shall have any liability for any
obligations of the Company under the Notes or this Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting a Note waives and releases all such liability. The waiver and
release are part of the consideration for issuance of the Notes. Such waiver may not be effective to waive liabilities under the federal securities laws and it is the view of the SEC that such a waiver is against public policy. 
  
 Section 10.8 Governing Law. This Indenture and the Notes shall be
governed by, and construed in accordance with, the laws of the State of New York. 
  
 Section 10.9 No Adverse Interpretation of Other Agreements. This Indenture may not be used to interpret any other indenture, loan or debt agreement of the Company or its Subsidiaries or of any other Person. Any
such indenture, loan or debt agreement may not be used to interpret this Indenture. 
  
 Section 10.10 Successors. All agreements of the Company in this Indenture and the Notes shall bind its successors. All agreements of the Trustee in this Indenture shall bind its successors. 
  

 -38- 

 Section 10.11 Severability. In case any provision in this Indenture or in the Notes shall be
invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
  

Section 10.12 Counterpart Originals. The parties may sign any number of copies of this Indenture. Each signed copy shall be an original, but all
of them together represent the same agreement. 
  
 Section 10.13
Table of Contents, Headings, etc. The Table of Contents, Cross-Reference Table and Headings of the Articles and Sections of this Indenture have been inserted for convenience of reference only, are not to be considered a part of this Indenture
and shall in no way modify or restrict any of the terms or provisions hereof. 
  
 [Signature page follows.] 
  
  

 -39- 

 IN WITNESS WHEREOF, the parties hereto have caused their duly authorized officers to execute and deliver
this Indenture, as of the date first above written. 
  

	GREENPOINT FINANCIAL CORP.
		
	By:	 	/S/    JEFFREY R. LEEDS
	 	

	 Name: Jeffrey R. Leeds

	 Title:   Executive Vice President
             and Chief Financial Officer

  

	THE BANK OF NEW YORK
		
	By:	 	/S/    JULIE SALOVITCH-MILLER
	 	

	 Name: Julie Salovitch-Miller

	 Title:   Vice President

 EXHIBIT A-1 
  
 (Form of Global Note) 
  
 3.20% Senior Notes Due 2008 
  
 GreenPoint Financial Corp. 
  
 THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY TRUST
COMPANY (“DTC”) OR A NOMINEE OF DTC. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN DTC OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND NO TRANSFER OF THIS
SECURITY (OTHER THAN A TRANSFER OF THIS SECURITY AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF DTC) MAY BE REGISTERED EXCEPT IN LIMITED CIRCUMSTANCES. 
  
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF DTC
TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT HEREON
IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE &
CO., HAS AN INTEREST HEREIN. 
  
 THIS SECURITY HAS NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THE HOLDER HEREOF, BY PURCHASING THIS SECURITY, AGREES FOR THE BENEFIT OF THE COMPANY THAT THIS SECURITY MAY NOT BE RESOLD, PLEDGED OR OTHERWISE TRANSFERRED
OTHER THAN (A)(1) TO THE COMPANY, (2) IN A TRANSACTION ENTITLED TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT, (3) SO LONG AS THIS SECURITY IS ELIGIBLE FOR RESALE PURSUANT TO RULE 144A UNDER THE SECURITIES ACT
(“RULE 144A”), TO A PERSON WHOM THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER WITHIN THE MEANING OF RULE 144A PURCHASING FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER TO WHOM NOTICE IS GIVEN
THAT THE RESALE, PLEDGE OR OTHER TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A, (4) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT TO AN INSTITUTIONAL ACCREDITED INVESTOR THAT IS PURCHASING SECURITIES IN AN AGGREGATE PRINCIPAL
AMOUNT OF AT LEAST $100,000 AND THAT, PRIOR TO SUCH TRANSFER, FURNISHES TO THE TRUSTEE A SIGNED LETTER CONTAINING CERTAIN REPRESENTATIONS AND WARRANTIES RELATING TO THE 
  

 A-1-1 

 RESTRICTIONS ON TRANSFER OF THE SECURITY EVIDENCED HEREBY (THE FORM OF LETTER CAN BE OBTAINED FROM SUCH TRUSTEE), (5) IN
ACCORDANCE WITH ANOTHER APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT (AND BASED UPON AN OPINION OF COUNSEL ACCEPTABLE TO THE COMPANY) OR (6) PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BEEN DECLARED EFFECTIVE
UNDER THE SECURITIES ACT AND (B) IN EACH CASE IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF EACH STATE OF THE UNITED STATES. AN INSTITUTIONAL ACCREDITED INVESTOR HOLDING THIS SECURITY AGREES IT WILL FURNISH TO THE COMPANY AND THE TRUSTEE SUCH
CERTIFICATES AND OTHER INFORMATION AS THEY MAY REASONABLY REQUIRE TO CONFIRM THAT ANY TRANSFER BY IT OF THIS SECURITY COMPLIES WITH THE FOREGOING RESTRICTIONS. THE HOLDER HEREOF, BY PURCHASING THIS SECURITY, REPRESENTS AND AGREES FOR THE BENEFIT OF
THE COMPANY THAT IT IS (1) A QUALIFIED INSTITUTIONAL BUYER WITHIN THE MEANING OF RULE 144A OR (2) AN INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(A)(1), (2), (3) OR (7) UNDER THE SECURITIES ACT AND THAT IT IS HOLDING
THIS SECURITY FOR INVESTMENT PURPOSES AND NOT FOR DISTRIBUTION 
  
 IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING
RESTRICTIONS. 
  

 A-1-2 

 CUSIP
                     
  
 3.20% Senior Notes Due 2008 
  

	No.                    
        	  	$                            

  
 GREENPOINT FINANCIAL
CORP. 
  
 promises to pay to Cede & Co. or registered assigns, the principal
sum of             dollars, as such sum may be increased or reduced as reflected on the records of the Trustee in accordance with Section 2.1(b) of the within-mentioned Indenture, on June
6, 2008. 
  
 Interest Payment Dates: June 6 and December 6 
  
 Record Dates: May 22 and November 21 
  

	GREENPOINT FINANCIAL CORP.
		
	By:	 	 
	 	

	 	 	 Name:
 Title:

  
 This is one of the Notes referred 
 to in the within-mentioned Indenture: 
  

	 THE BANK OF NEW YORK,
 as Trustee
	 	 	 	 
				
	By:	 	 	 	 	 	Dated:
	 	 	
 Name:
 Title:
	 	 	 	 	 	 

  

 A-1-3 

 (Reverse of Note) 
  

3.20% Senior Notes Due 2008 
  
 Capitalized terms used herein shall have the meanings assigned to them in the Indenture referred to below unless otherwise indicated. 
  
         1. Interest.
GreenPoint Financial Corp. (the “Company”), a Delaware corporation, promises to pay interest on the Principal Amount of this Note at 3.20% per annum from December 6, 2003 until maturity and shall pay the Special Interest Premium, if any,
payable pursuant to Section 2(e) of the Registration Rights Agreement referred to below. The Company shall pay interest and Special Interest Premium, if any, semi-annually on June 6 and December 6 of each year, or if any such day is not a Business
Day, on the next succeeding Business Day (each, an “Interest Payment Date”). Interest on the Notes will accrue from the most recent date to which interest has been paid or, if no interest has been paid, from the date of issuance;
provided, that if there is no existing Default in the payment of interest, and if this Note is authenticated between a record date referred to on the face hereof and the next succeeding Interest Payment Date, interest shall accrue from such
next succeeding Interest Payment Date; provided, further, that the first Interest Payment Date shall be December 6, 2003. The Company shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue
principal from time to time on demand at a rate that is 1% per annum in excess of the then applicable interest rate, to the extent lawful; it shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue
installments of interest and Special Interest Premium, if any, (without regard to any applicable grace periods) from time to time on demand at the same rate to the extent lawful. Interest will be computed on the basis of a 360-day year of twelve
30-day months. 
  
         2. Method of Payment. The Company will pay interest on the Notes and Special Interest Premium, if any, to the Persons who are registered Holders of Notes at the close of business on the
May 22 or November 21 next preceding the Interest Payment Date, even if such Notes are canceled after such record date and on or before such Interest Payment Date, except as provided in Section 2.12 of the Indenture (as herein defined) with respect
to defaulted interest. The Notes will be payable as to principal, interest and Special Interest Premium, if any, at the office or agency of the Paying Agent (which may be the Company), or, at the option of the Company, payment of interest and
Special Interest Premium, if any, may be made by check mailed to the Holders at their addresses set forth in the register of Holders, and provided that all payments of principal, interest and Special Interest Premium, if any, with respect to Notes a
Holder of which owns at least $50 million aggregate Principal Amount of Notes and has given wire transfer instructions to the Company at least ten Business Days prior to the applicable payment date, will be required to be made by wire transfer of
immediately available funds to the accounts specified by the Holder thereof. Such payment shall be in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts.

  
         3. Paying
Agent and Registrar. Initially, The Bank of New York, the Trustee (“Trustee”) under the Indenture, will act as Paying Agent and Registrar. The Company may 
  

 A-1-4 

 change any Paying Agent or Registrar without notice to any Holder. The Company or any of its Subsidiaries may act in any
such capacity. 
  
         4. Indenture. The Company issued this Note under an Indenture dated as of June 6, 2003, as amended or supplemented from time to time (“Indenture”), between the Company and the
Trustee. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the TIA. The Notes are subject to all such terms, and Holders are referred to the Indenture and the TIA for a statement of
such terms. To the extent any provision of this Note conflicts with the express provisions of the Indenture, the provisions of the Indenture shall govern and be controlling. 
  
         5. Optional Redemption. The Notes will not be subject to redemption
at any time at the option of the Company. 
  
         6. Denominations, Transfer, Exchange. The Notes are in registered form without coupons in denominations of $1,000 and integral multiples thereof. The transfer of Notes may be registered
and Notes may be exchanged as provided in the Indenture. The Registrar and the Trustee may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and the Company may require a Holder to pay any taxes and
fees required by law or permitted by the Indenture. The Company need not exchange or register the transfer of any Notes during the period between a record date and the next succeeding Interest Payment Date. 
  
         7. Persons Deemed
Owners. The registered Holder of a Note may be treated as its owner for all purposes. 
  
         8. Amendment, Supplement and Waiver. Subject to certain exceptions, the Indenture or the Notes may be amended or supplemented with the consent of the Holders of
at least a majority in Principal Amount of the then outstanding Notes voting as a single class, and, subject to Sections 6.4, 6.6 and 6.7 of the Indenture, any existing Default or Event of Default (other than a Default or Event of Default in the
payment of the principal of, interest on or Special Interest Premium, if any, on the Notes, except a payment default resulting from an acceleration that has been rescinded) may be waived with the consent of the Holders of a majority in Principal
Amount of the then outstanding Notes voting as a single class (including consents obtained in connection with a tender offer or exchange offer for, or purchase of the Notes). Subject to Sections 6.4, 6.6 and 6.7 of the Indenture, compliance with any
provision of the Indenture or the Notes may be waived with the consent of the Holders of a majority in Principal Amount of the then outstanding Notes voting as a single class. Without the consent of any Holder of a Note, the Indenture or the Notes
may be amended or supplemented to cure any ambiguity, defect or inconsistency; to provide for uncertificated Notes in addition to or in place of Definitive Notes or to alter the provisions of Article II of the Indenture (including the related
definitions) in a manner that does not adversely affect any Holder; to provide for the assumption of the Company’s obligations to the Holders of the Notes by a successor to the Company pursuant to Article V of the Indenture; to make any change
that would provide any additional rights or benefits to the Holders of the Notes; to make any change that is not inconsistent with the Indenture and does not adversely affect the legal rights under the Indenture of any Holder of 
  

 A-1-5 

 Notes; or to comply with the requirements of the SEC in order to effect or maintain the qualification of the Indenture
under the TIA. 
  
         9. Defaults and Remedies. An “Event of Default” occurs if: (i) the Company defaults in the payment of any installment of interest or Special Interest Premium, if any, upon any
of the Notes as and when the same shall become due and payable, and such default continues for a period of 30 days; (ii) the Company defaults in the payment of all or any part of the principal of any of the Notes as and when the same shall become
due and payable either at maturity, by declaration of acceleration or otherwise; (iii) the Company fails to perform any other covenant or agreement on the part of the Company contained in the Notes or in the Indenture and such failure continues for
a period of 60 days after the date on which notice specifying such failure, stating that such notice is a “Notice of Default” under the Indenture and demanding that the Company remedy the same, shall have been given to the Company by the
Trustee, or to the Company and the Trustee by the Holders of at least 25% in aggregate Principal Amount of the Notes at the time outstanding; (iv) the Company defaults in the scheduled payment of principal, or interest of or on any Indebtedness in
excess of $25,000,000 which constitutes an event of default as defined in any instrument of the Company under which such Indebtedness is or may be issued, or by which such Indebtedness is or may be secured or evidenced, which event of default has
resulted in the acceleration of such Indebtedness, or any default occurring in payment of any such Indebtedness at final maturity (and after the expiration of any applicable grace periods); (v) a court having jurisdiction in the premises shall enter
a decree or order for relief in respect of the Company or any Material Subsidiary in an involuntary case or proceeding under any applicable bankruptcy, insolvency, reorganization or other similar law now or hereafter in effect, or a decree or order
adjudging the Company or any Material Subsidiary a bankrupt or insolvent, or approving as properly filed a petition seeking reorganization, arrangement, adjustment, or composition of or in respect of the Company or any Material Subsidiary under any
applicable federal or state law, or appointing a receiver, liquidator, assignee, custodian, trustee, sequestrator or similar official of the Company or any Material Subsidiary or for any substantial part of its property or ordering the winding up or
liquidation of its affairs, shall have been entered, and such decree or order shall remain unstayed and in effect for a period of 90 consecutive days; or (vi) the Company or any Material Subsidiary shall commence a voluntary case or proceeding under
any applicable federal or state bankruptcy, insolvency, reorganization or other similar law now or hereafter in effect or any other case or proceeding to be adjudicated a bankrupt or insolvent, or consent to the entry of a decree or order for relief
in an involuntary case or proceeding under any such law, or to the commencement of any bankruptcy or insolvency case or proceeding against the Company or any Material Subsidiary, or the filing by the Company or any Material Subsidiary of a petition
or answer to consent seeking reorganization or relief under any such applicable federal or state law, or the consent by the Company or any Material Subsidiary to the filing of such petition or to the appointment of or the taking possession by a
custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or any Material Subsidiary or of any substantial part of its property, or the making by the Company or any Material Subsidiary of an assignment
for the benefit of creditors, or the taking of action by the Company or any Material Subsidiary in furtherance of any such action. If any Event of Default (other than an Event of Default specified in clause (v) or (vi) hereof) occurs and is
continuing, the Trustee or the Holders of at least 25% in Principal Amount of the then outstanding Notes may declare the Principal Amount of all the Notes and interest and Special Interest Premium, if any, to be due and payable 
  

 A-1-6 

 immediately. If an Event of Default specified in clause (v) or (vi) hereof occurs, the principal of, interest accrued on,
and Special Interest Premium if any, on all outstanding Notes shall be due and payable without further action or notice. Holders of the Notes may not enforce the Indenture or the Notes except as provided in the Indenture. The Trustee may withhold
from Holders of the Notes notice of any continuing Default or Event of Default (except a Default or Event of Default relating to the payment of principal, interest or Special Interest Premium, if any) if it determines that withholding notice is in
their interest. The Holders of a majority in aggregate Principal Amount of the then outstanding Notes by written notice to the Trustee may on behalf of the Holders of all of the Notes waive any existing Default or Event of Default and its
consequences under the Indenture, except a continuing Default or Event of Default in the payment of the principal of, interest on or Special Interest Premium, if any, on the Notes. 
  
         10. Trustee Dealings With Company. The Trustee, in its
individual or any other capacity, may become the owner or pledgee of Notes and may otherwise deal with the Company or any Affiliate of the Company with the same rights it would have if it were not the Trustee. 
  
         11. No Recourse Against
Others. No director, officer, employee, incorporator or stockholder of the Company, as such, shall have any liability for any obligations of the Company under the Notes, the Indenture or for any claim based on, in respect of, or by reason of,
such obligations or their creation. Each Holder by accepting a Note waives and releases all such liability. The waiver and release are part of the consideration for the issuance of the Notes. Such waiver may not be effective to waive liabilities
under the federal securities laws and it is the view of the SEC that such a waiver is against public policy. 
  
         12. Authentication. This Note shall not be valid until authenticated by the manual signature
of the Trustee or an authenticating agent. 
  
         13. Abbreviations. Customary abbreviations may be used in the name of a Holder or an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (=
joint tenants with right of survivorship and not as tenants in common), CUST (= custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 
  
         14. Additional Rights of Holders of Restricted Global Notes and Restricted Definitive Notes. In
addition to the rights provided to Holders of Notes under the Indenture, Holders of Restricted Global Notes and Restricted Definitive Notes shall have all the rights set forth in the Registration Rights Agreement dated as of June 6, 2003, among the
Company and the Initial Purchasers named therein (the “Registration Rights Agreement”). 
  
         15. CUSIP Numbers. Pursuant to a recommendation promulgated by the Committee on Uniform Security
Identification Procedures, the Company has caused CUSIP numbers to be printed on the Notes. No representation is made as to the accuracy of such numbers printed on the Notes and reliance may be placed only on the other identification numbers placed
thereon. 
  

 A-1-7 

         16. Available Information. The Company will
furnish to any Holder upon written request and without charge a copy of the Indenture and/or the Registration Rights Agreement. Requests may be made to: 
  
 GreenPoint Financial Corp. 
 90 Park Avenue

 New York, New York 10016 
 Attention: General Counsel 
  
         17. Counterparts. This Note may be executed by one or more of the parties to this Note on any number of separate counterparts, and all of said counterparts taken together shall be
deemed to constitute one and the same instrument. 
  

 A-1-8 

 Assignment Form 
  

To assign this Note, fill in the form below: (I) or (we) assign and transfer this Note to 
  

 (Insert assignee’s Social Security or Tax Identification number)

  

  

  

  

 (Print or type assignee’s name, address and zip code) 
  
 and irrevocably appoint
                                        
                             to transfer this Note on the books of the Company. The agent may substitute
another to act for him. 
  
 Date:
                             
  

	 Your signature:
                                        
            
 (Sign exactly as your name appears on the face of this Note)
  
 Tax Identification No.:
                                    
 SIGNATURE GUARANTEE:

	
	 
	

	Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar, which requirements include membership or participation
in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for, STAMP, all in accordance with the Securities
Exchange Act of 1934, as amended.

  

 A-1-9 

 EXHIBIT A-2 
  
 (Form of Definitive Note) 
  
 THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THE HOLDER HEREOF, BY PURCHASING THIS
SECURITY, AGREES FOR THE BENEFIT OF THE COMPANY THAT THIS SECURITY MAY NOT BE RESOLD, PLEDGED OR OTHERWISE TRANSFERRED OTHER THAN (A)(1) TO THE COMPANY, (2) IN A TRANSACTION ENTITLED TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE
SECURITIES ACT, (3) SO LONG AS THIS SECURITY IS ELIGIBLE FOR RESALE PURSUANT TO RULE 144A UNDER THE SECURITIES ACT (“RULE 144A”), TO A PERSON WHOM THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER WITHIN THE MEANING OF RULE
144A PURCHASING FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER TO WHOM NOTICE IS GIVEN THAT THE RESALE, PLEDGE OR OTHER TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A, (4) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT TO AN INSTITUTIONAL ACCREDITED INVESTOR THAT IS PURCHASING SECURITIES IN AN AGGREGATE PRINCIPAL AMOUNT OF AT LEAST $100,000 AND THAT, PRIOR TO SUCH TRANSFER, FURNISHES TO THE TRUSTEE A SIGNED LETTER CONTAINING CERTAIN
REPRESENTATIONS AND WARRANTIES RELATING TO THE RESTRICTIONS ON TRANSFER OF THE SECURITY EVIDENCED HEREBY (THE FORM OF LETTER CAN BE OBTAINED FROM SUCH TRUSTEE), (5) IN ACCORDANCE WITH ANOTHER APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT (AND BASED UPON AN OPINION OF COUNSEL ACCEPTABLE TO THE COMPANY) OR (6) PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BEEN DECLARED EFFECTIVE UNDER THE SECURITIES ACT AND (B) IN EACH CASE IN ACCORDANCE WITH ANY APPLICABLE
SECURITIES LAWS OF EACH STATE OF THE UNITED STATES. AN INSTITUTIONAL ACCREDITED INVESTOR HOLDING THIS SECURITY AGREES IT WILL FURNISH TO THE COMPANY AND THE TRUSTEE SUCH CERTIFICATES AND OTHER INFORMATION AS THEY MAY REASONABLY REQUIRE TO CONFIRM
THAT ANY TRANSFER BY IT OF THIS SECURITY COMPLIES WITH THE FOREGOING RESTRICTIONS. THE HOLDER HEREOF, BY PURCHASING THIS SECURITY, REPRESENTS AND AGREES FOR THE BENEFIT OF THE COMPANY THAT IT IS (1) A QUALIFIED INSTITUTIONAL BUYER WITHIN THE MEANING
OF RULE 144A OR (2) AN INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(A)(1), (2), (3) OR (7) UNDER THE SECURITIES ACT AND THAT IT IS HOLDING THIS SECURITY FOR INVESTMENT PURPOSES AND NOT FOR DISTRIBUTION. 

 
 IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR
AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. 
  

 A-2-1 

 CUSIP
                         
  

3.20% Senior Notes Due 2008 
  

	No.                        	  	$                            

  
 GREENPOINT FINANCIAL
CORP. 
  
 promises to pay to Cede & Co. or registered assigns, the principal
sum of                              dollars on June 6, 2008. 
  
 Interest Payment Dates: June 6 and December 6 
  
 Record Dates: May 22 and November 21 
  

	 	 	 	 	 	 	 	 	 GREENPOINT FINANCIAL CORP.

					
	 	 	 	 	 	 	By:	 	 
	 	 	 	 	 	 	 	

	 	 	 	 	 	 	 	 	 Name:
 Title:

					
	 	 	 	 	 	 	By:	 	 
	 	 	 	 	 	 	 	

	 	 	 	 	 	 	 	 	 Name:
 Title:

				
	 This is one of the Notes referred
 to in the within-mentioned Indenture:
	 	 	 	 	 	 
			
	 THE BANK OF NEW YORK,
 as Trustee
	 	 	 	 
				
	By:	 	 	 	 	 	Dated:
	 	
	 	 	 	 
	 	 	 Name:
 Title:
	 	 	 	 	 	 

  

 A-2-2 

 [FORM OF REVERSE SIDE IS IDENTICAL TO EXHIBIT A-1] 
  
  

 A-2-3 

 EXHIBIT B 
 (Form of Certificate of Transfer) 
  
 GreenPoint Financial Corp. 
 90 Park Avenue 
 New York, New York 10016 
 Attention: General Counsel 
  
 The Bank of New York 
 101 Barclay Street 
 Floor 8W 
 New York, New York 10286 
 Attention: Corporate Trust Administration 
  

	 	Re:	 	3.20% Senior Notes Due 2008 

  
         Reference is hereby made to the Indenture, dated as of June 6, 2003 (the “Indenture”), between
GreenPoint Financial Corp. (the “Company”) and The Bank of New York, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture.
             (the “Transferor”) owns and proposes to transfer the Note[s] or interest in such Note[s] specified in Annex A hereto (the “Surrendered Notes”), in
the principal amount of $             in such Note[s] or interests (the “Transfer”), to              (the
“Transferee”), which transfer complies with the restrictive legend set forth on the face of the Surrendered Notes for the reason checked below. In connection with the Transfer, the Transferor hereby certifies that: 
  

	 	 ̈	 	A transfer of the Surrendered Notes is made to the Company; or 

  

	 	 ̈	 	A transfer of the Surrendered Notes is exempt from the registration requirements of the U.S. Securities Act of 1933, as amended (the “Securities Act”) under Rule 144A; or

  

	 	 ̈	 	The transfer of the Surrendered Notes complies with Rule 144A under the Securities Act and is made to a person whom the transferor reasonably believes is a “qualified
institutional buyer” within the meaning of Rule 144A purchasing for its own account or for the account of a qualified institutional investor to whom notice is given that the transfer is being made in reliance on Rule 144A; or

  

	 	 ̈	 	The transfer of the Surrendered Notes is pursuant to an exemption from registration under the Securities Act to an “institutional accredited investor” as defined in Rule
501(a)(1), (2), (3) or (7) of Regulation D under the Securities Act that is purchasing Surrendered Notes in an aggregate principal amount of at least $100,000; or 

  

	 	 ̈	 	The transfer of the Surrendered Notes is pursuant to an effective registration statement under the Securities Act, or 

  

	 	 ̈	 	The transfer of the Surrendered Notes is pursuant to another available exemption 

  
  

 B-1 

         from the registration requirement of the Securities Act.

  
 and unless the box below is checked, the undersigned confirms
that, to the undersigned’s knowledge, such Notes are not being transferred to an “affiliate” of the Company as defined in Rule 144 under the Securities Act (an “Affiliate”). 
  

	 	 ̈	 	The transferee is an Affiliate of the Company. 

  

 B-2 

         This certificate and the statements contained herein are
made for your benefit and the benefit of the Company. 
  

	
	 
	

	 [Insert Name of Transferor]

		
	By:	 	 
	 	

	 	 	 Name:
 Title:

 Dated:
                        ,              
  
  

 B-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00053-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00053-of-00352.parquet"}]]